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Abstract
OCD (obsessive-compulsive disorder) is a chronic and debilitating psychiatric condition 
characterized by intrusive and persistent thoughts (obsessions) and repetitive behaviors 
(compulsions) that become ritualistic in an attempt to escape the obsessions. Currently 
there is a paucity o f animal models with robust and spontaneous (non-drug or non- 
behaviorally induced) compulsive-like behaviors. This study is aimed at validating a 
novel robust and spontaneous genetic mouse model of OCD. The compulsive-like nest- 
building behavior in mice selected for high levels of nest-building behavior (BIG) has 
good face validity, with a behavioral phenotype that resembles hoarding behavior 
characteristic of OCD. In addition, male and female BIG mice displayed compulsive­
like digging behavior relative to mice selected for low levels of nest-building behavior 
(SMALL), as assessed by the marble-burying test. Both chronic oral fluoxetine and 
clomipramine treatment reduced compulsive-like nest-building behavior in male BIG 
mice. Furthermore, chronic oral fluoxetine administration decreased nest-building 
behavior of BIG mice in a dose-dependent manner, while desipramine, an 
antidepressant not effective for treating OCD, did not significantly alter this behavior. 
The administration of fluoxetine did not cause a decrease in general locomotor 
behavior. These findings suggest that the nest-building phenotype has predictive 
validity. In addition, chronic oral fluoxetine treatment reduced compulsive-like digging 
behavior in male and female BIG mice as compared to SMALL mice. Gender effects 
were also found in treatment response. Clomipramine did not reduce nest-building in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
female BIG mice in a dose-dependent manner, which is consistent with previous 
studies. These data are in contrast to previous studies using BIG male mice which had a 
significant decrease in nest-building behavior with oral clomipramine. These results are 
consistent with studies on humans, which have found gender differences in the 
treatment effects of antidepressants. Additional construct validity is implicated by the 
results of targeted serotonergic lesions o f the raphe nuclei in male BIG mice, which 
reduced repetitive nest-building behavior. More research is necessary to confirm the 
appropriateness o f this model for human OCD; however, this model is promising based 
on the data that support good face, predictive and construct validity.
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1CHAPTER 1 
General Introduction
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric condition in humans 
that is characterized by intrusive and persistent thoughts (obsessions) and repetitive 
behaviors (compulsions) (DSM-IV, American Psychiatric Association, 1994). OCD 
affects approximately 2% of the US population to an extent that prohibits those affected 
from leading normal lives. OCD associated costs in the US tops $8 billion per year. 
Therefore, this disease has high social and economic impact. The neural mechanisms 
that control OCD are poorly understood. The small number of animal models, which 
reveal consistent and spontaneous (non drug-induced or non behaviorally-induced) 
differences in compulsive-like behaviors, contributes to this lack of understanding.
An effective animal model of OCD will need to focus on specific behavioral, 
neurochemical, and structural brain anomalies that are homologous to OCD in humans. 
Previous researchers have specified certain requirements for an animal model system, 
which include face, predictive, and construct validity (KorfF and Harvey, 2006; 
McKinney and Bunney, 1969; Wilner, 1991). An animal model of OCD should have 
good face validity, which includes symptoms that are reasonably similar to human 
symptoms and behavioral changes that are objectively measurable (Korff and Harvey, 
2006; McKinney and Bunney, 1969; Wilner, 1991). Predictive validity is also 
necessary, such that treatments effective in OCD (e.g., specific serotonin re-uptake
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
inhibitors (SSRIs) and clomipramine) should have the same effect on the animal 
condition (Korff and Harvey, 2006; McKinney and Bunney, 1969; Wilner, 1991). An 
animal model should also have construct validity in which the model either relies on or 
elucidates the same underlying neural mechanisms responsible for OCD (Korff and 
Harvey, 2006; Overall, 2000). Ultimately, the more types of validity an animal model of 
OCD is able to satisfy, the more useful it will be for investigating the human condition. 
The majority o f current animal models of OCD are laboratory-based and induced, and 
can be classified as ethological, pharmacological, or genetic.
Ethological models include naturally occurring behaviors, e.g., canine acral-lick 
dermatitis (a stereotypic behavior resulting in self-mutilation), tail chasing, weaving and 
fur chewing. They may also be based on natural behaviors that occur after some 
behavioral manipulations, e.g., post-training attenuation, food restriction-induced 
wheel-running, and excessive lever pressing, which induce compulsive-like behavior by 
conditioning the animal (Joel and Avisar, 2001; Korff and Harvey, 2006; Man et al., 
2004; Ricciardi and Hurley, 1990; Stein et al., 1994). Ethological models of OCD 
appear to closely resemble the compulsive rituals, which are often repetitive, pointless, 
and inappropriate in context (Man et a l, 2004). However, these models use behaviors 
that arise from external conflict or stimuli, rather than from internal conflict as in OCD 
patients (Szechtman et al., 1999). Therefore, the neural pathways involved may be 
different.
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Pharmacological models of OCD are the most frequently used models and target either 
the serotonergic or dopaminergic pathways. Often the animals in these models exhibit 
compulsive-like behaviors that can be attenuated by administration o f drugs commonly 
used for OCD, indicating that these behaviors may have similar neural mechanisms as 
compulsions in OCD in humans (Demeulemeester et al., 2001; Szechtman et al., 1998, 
2001; Van Kuyck et al., 2003). However, a drawback with the drug-induced models is 
that they cannot provide information regarding the underlying neurobiology of the 
disorder and are generally not suitable for predicting the onset of action or efficacy of 
potential novel treatments (D’haenen and Andrews, 2000).
Genetic models using transgenic or knockout mice offer interesting insights into 
pathways possibly involved in OCD. Dopamine 1 receptor transgenic (DICT-7) mice, a 
model of cortical-limbic neurostimulation, resemble cortical-limbic-induced compulsive 
disorders, such as OCD and related disorders (Campbell et al., 1999; McGrath et al., 
1999; Nordstrom and Burton, 2002). In addition, mice with specific mutations in the 
serotonin system, e.g., 5-HT2C knock-outs, also exhibit compulsive-like behaviors 
(Heisler and Tecott, 1999), but these mice also exhibit an excess o f abnormalities, e.g., 
obesity, abnormal cognitive processes, and seizure susceptibility (Heisler and Tecott, 
1999; Tecott and Abdallah, 2003). These and other genetic models offer insights into 
OCD spectrum disorders, but these models alone do not give a complete picture of 
OCD in humans, which likely is a combination o f several neuronal and signaling 
pathways.
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The model proposed in this dissertation uses mice which have a stable and spontaneous 
nesting phenotype. Bidirectional selection for nest-building behavior in house mice 
(Mus musculus) has resulted in a 40-fold difference between big (BIG) and small 
(SMALL) nest-building mice in the amount of cotton used for a nest, while non­
selected control mice (CONTROL) have intermediate values (Bult and Lynch, 1996, 
1997, 2000; Lynch, 1980). The mice were bidirectionally selected for nesting behavior 
for a total of 57 generations and subsequently maintained by random breeding within 
the mouse lines for over 50 generations. Random breeding within each mouse line has 
not diminished the nesting difference among the selected lines. Differences in nest- 
building behavior among the BIG, CONTROL, and SMALL mice are highly 
predictable and reproducible from generation to generation (Bult and Lynch, 1996, 
1997, 2000; Lynch, 1980).
Nest-building behavior in BIG mice is characterized by rapid and repeated movements 
of the front legs and paws to pull in the cotton through the metal bars of the cage top. 
Animals also pull in cotton with their teeth through repetitive biting and pulling 
motions. One o f the most striking features of this nest-building behavior is that most 
BIG mice start pulling cotton into their cage within 1 minute after the cotton is placed in 
the cage top, even if they have had no prior exposure to cotton. In contrast, the SMALL 
mice spend little-to-no time interacting with the cotton (unpublished data). This 
behavior appears to have good face validity as a compulsive-like behavior seen in 
human OCD patients.
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The studies described here aim to validate mice selected for compulsive-like nest- 
building behavior as a good animal model o f OCD in humans. In order to do this, I 
examined marble-burying behavior as an independent compulsive-like behavior and the 
effects on nest-building behavior and marble-burying of pharmaceutical manipulations 
with drugs that are commonly effective, as well as those not effective, for the treatment 
of OCD in humans. Both male (Chapter 2) and female (Chapter 3) mice were used in 
order to further elucidate any possible sex differences that may exist in these 
compulsive-like behaviors and the pharmacological treatment of these behaviors. 
Involvement of serotonergic pathways was further studied by performing targeted 
lesions of serotonergic areas of the brain and then examining the effects on compulsive­
like nest-building behavior, as well as a control behavior (wheel-running) (Chapter 4).
This dissertation describes the compulsive-like nest-building mouse model, which 
potentially could be used for rapid progress in the understanding of mechanisms 
underlying OCD by using a species for which a wealth o f behavioral, physiological, and 
genetic knowledge is available. Developing the nesting mice as a screening tool for 
drug and therapeutic development may then be possible. Gaining insights into 
mechanisms that control compulsive-like behaviors will contribute to the future 
development of more effective treatments and a potential cure for OCD.
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CHAPTER 2 
Nest-Building Behavior in House Mice (Mus musculus), a Potential Model of 
Obsessive-Compulsive Disorder in Humans*
2.1. Abstract
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric condition that is 
characterized by intrusive and persistent thoughts (obsessions) and repetitive behaviors 
(compulsions). The small number of animal models available that reveal consistent and 
spontaneous differences in compulsive-like behaviors contributes to a paucity of studies 
and a lack of knowledge o f the underlying neural mechanisms of OCD. Bidirectional 
selection for thermoregulatory nest-building behavior in house mice, Mus Musculus, has 
resulted in a 40-fold difference in the amount of cotton used for nest-building in high 
(BIG) and low (SMALL) selected lines. The nest-building behavior of the BIG mice 
appears to be compulsive-like. The goal of this research was to provide support towards 
the validation of compulsive-like nest-building mice as an animal model of human 
OCD. Pharmacological administration of fluoxetine and clomipramine, drugs both 
effective in treating OCD in humans, were found to reduce compulsive-like nest- 
building behavior in BIG mice, while desipramine, an antidepressant not effective in
* In preparation for the Journal o f Pharmacology and Experimental Therapeutics. 
DM Greene, EA Van der Zee, DK Raap, MR Castillo, KA Alexander, T Burrow, H 
Foltz, M Slater, A Bult-Ito
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treating OCD, had no significant effect. In addition, fluoxetine reduced compulsive-like 
nest-building in a dose-dependent manner and also had latency to peak effect, as seen in 
human OCD patients. BIG and SMALL mice were tested for another compulsive-like 
behavior, digging. BIG male mice expressed compulsive-like digging behavior, as 
assessed by the marble-burying test. Compulsive-like digging behavior was 
significantly reduced by fluoxetine treatment. The responsiveness o f the BIG male mice 
to fluoxetine and clomipramine, but not to the antidepressant desipramine, indicates that 
these mice have good predictive validity as a mouse model of OCD. In addition, the 
compulsive-like digging behavior provides additional support for the face validity of 
this mouse model of OCD. In conclusion, these mice are a promising new animal model 
for the further investigation of OCD and its underlying neural mechanisms in humans.
2.2. Introduction
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric condition that is 
characterized by intrusive and persistent thoughts (obsessions) and repetitive behaviors 
(compulsions) (DSM-IV, American Psychiatric Association, 1994). The neural 
mechanisms that control OCD are poorly understood. The small number of animal 
models available that reveal consistent and spontaneous (non drug-induced or non 
behaviorally-induced) differences in compulsive-like behaviors contributes to this lack 
of understanding. Compulsive-like behaviors in existing models are typically induced, 
then evaluated and used to represent compulsions in humans with OCD. The majority of
11
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current animal models of OCD are laboratory-based and induced, and can be classified 
as ethological, pharmacological, and genetic.
Ethological models include naturally occurring behaviors, such as canine acral-lick 
dermatitis (a stereotypic behavior resulting in self-mutilation), tail chasing, weaving, 
and fiir chewing (Korff and Harvey, 2006; Stein et al., 1994) and behaviors that are 
induced by stress or conflict such as grooming, cleaning, and pecking (Korff and 
Harvey, 2006; Ricciardi and Hurley, 1990). Canine acral-lick dermatitis is the best 
documented naturally occurring model and closely resembles the symptomology and 
inducing conditions seen in OCD (Dodman et al., 1997; Rapoport et al., 1992) and 
responds to common OCD treatments (Goldberg and Rapoport, 1992; Stein et al., 1992, 
1998). However, the difficulty of obtaining adequate sample sizes makes this model 
cost prohibitive (Man et al., 2004).
Other ethological models are based on natural behaviors that occur after some 
behavioral manipulations (e.g., post-training attenuation, food restriction-induced wheel 
running, excessive lever pressing), which induce compulsive-like behaviors by 
conditioning the animal to perform a behavior in response to a stimulus and then 
measuring the time to extinction o f that behavior (Joel and Avisar, 2001; Man et al., 
2004). Excessive lever pressing is a behavioral paradigm that is generated when reward 
presentation is regularly scheduled and then dissociated from the animal’s behavior 
(Joel and Avisar, 2001; Korff and Harvey, 2006). The exposure to non-reward produces
12
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an increase in operant behavior, which can then be attenuated by fluoxetine, but not by 
the anxiolytic drug diazepam, which gives the model good predictive validity (Joel and 
Avisar, 2001; Korff and Harvey, 2006). Lever pressing in rats is enhanced following 
lesions to the orbital cortex but not to the basolateral amygdala or dorsal medial 
prefrontal cortex (Joel et al., 2005), indicating that this model may have good construct 
validity (Korff and Harvey, 2006). Ethological models of OCD appear to closely 
resemble the compulsive rituals, which are often repetitive, pointless, and inappropriate 
in context (Man et al., 2004). However, these models use behaviors that arise from 
external conflict or stimuli, rather than from internal conflict as in OCD patients. 
Therefore, the neural pathways involved may be different (Szechtman et al., 1999).
Pharmacological models of OCD are the most frequently used animal models and target 
either the serotonergic or dopaminergic pathways. The 5-HTia agonist, 8-OH-DPAT 
and the D2/D3 dopamine agonist, quinpirole, have both been used to induce 
compulsive-like behaviors in rodents (Demeulemeester et al., 2001; Szechtman et al., 
1998, 2001; Van Kuyck et al., 2003). The resulting compulsive-like behaviors can be 
attenuated by administration of drugs commonly used for OCD, indicating that these 
behaviors may have similar mechanisms as compulsions in OCD (Demeulemeester et 
al., 2001; Szechtman et al., 1998, 2001; Van Kuyck et al., 2003). However, a drawback 
with the drug-induced models is that they cannot provide information regarding the 
underlying neurobiology of the disorder and are generally not suitable for predicting the 
onset of action or efficacy of potential novel treatments (D’haenen and Andrews, 2000).
13
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Genetic models using transgenic or knockout mice offer interesting insights into neural 
pathways possibly involved in OCD. Dopamine receptor 1 transgenic (DICT-7) mice, a 
model of cortical-limbic neurostimulation, resemble cortical-limbic-induced compulsive 
disorders in humans, such as OCD, and other related disorders, such as Tourette’s 
syndrome (Campbell et al., 1999; McGrath et al., 1999; Nordstrom and Burton, 2002). 
In addition, mice with specific mutations in the serotonin system, e.g., 5-HT2C knock­
outs, also exhibit compulsive-like behaviors (Heisler and Tecott, 1999), but these mice 
also exhibit an excess of abnormalities, such as obesity, abnormal cognitive processes, 
and seizure susceptibility (Heisler and Tecott, 1999; Tecott and Abdallah, 2003). These 
and other genetic models offer mechanistic insights into OCD spectrum disorders, but 
these models alone do not give a complete understanding of OCD in humans, which 
likely involves the disruption or dysfunction of several neuronal pathways.
In order for an animal model o f OCD to be effective, it will need to focus on specific 
behavioral, neurochemical, and structural brain anomalies that are homologous to OCD 
in humans. Previous researchers have specified certain requirements for an animal 
model system, which include face, predictive and construct validity (Korff and Harvey, 
2006; McKinney and Bunney, 1969; Wilner, 1991). Face validity is comprised of 
homologous symptomology to human OCD patients, as well as objectively measurable 
behavioral changes and subjective states in the animal model (Korff and Harvey, 2006; 
McKinney and Bunney, 1969; Wilner, 1991). Predictive validity is determined by 
assessing if treatment responses in the animal model are similar to those seen in human
14
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patients (Korff and Harvey, 2006; McKinney and Bunney, 1969; Wilner, 1991). An 
animal model should also have construct validity in which the model either is based on 
or elucidates the same underlying neural mechanisms responsible for OCD (Korff and 
Harvey, 2006; Overall, 2000). Ultimately, an animal model of OCD will be more useful 
for investigating the underlying neural mechanisms, treatment and ultimately a cure for 
OCD, the more types of validity it is able to satisfy.
The model proposed in this paper uses nesting mice which have a stable and 
spontaneous nesting phenotype. Bidirectional selection for nest-building behavior in 
house mice {Mus musculus) has resulted in a 40-fold difference between big (BIG mice) 
and small (SMALL mice) nest-builders in the amount of cotton used for a nest, while 
non-selected controls (CONTROL mice) have intermediate values (Fig. 2.1; Bult and 
Lynch, 1996, 1997, 2000; Lynch, 1980). The mice were bi-directionally selected for 
nesting behavior for a total of 57 generations (Fig. 2.1; Bult and Lynch 1996, 1997, 
2000; Lynch, 1980) and subsequently maintained by random breeding within the mouse 
lines for over 50 generations. Random breeding within each mouse line has not 
diminished the nesting difference among the selected lines (unpublished data). As 
shown in Figure 2.1, differences in nest-building behavior among the BIG, CONTROL, 
and SMALL mice are highly predictable and reproducible from generation to 
generation.
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Nest-building behavior in these mice is characterized by rapid and repeated movements 
of the front legs and paws to puli in the cotton through the metal bars of the cage top. 
Animals also pull in cotton with their teeth through repetitive biting and pulling 
motions. One of the most striking features of nest-building behavior is the observation 
that most BIG mice will start pulling cotton into their cage within 1 minute after the 
cotton is placed in the cage top, even if they have had no prior exposure to cotton. In 
contrast, the SMALL mice spend little to no time interacting with the cotton 
(unpublished data). These observations provide a strong foundation for the face validity 
of the compulsive-like nest -building mouse model.
To establish stronger face validity of these mice having a compulsive-like phenotype, 
we tested them for marble-burying, as a measure of compulsive-like digging behavior 
(Gyertyan, 1995; Njung’e and Handley, 1991; Takcuchi et al ,  2002) as well as for nest- 
building behavior. Daily wheel-running behavior and performance in an elevated plus- 
maze and open field were used as control behaviors.
The studies described here also aim to reveal whether excessive nest-building behavior 
has good predictive validity as an animal model of OCD in humans. Currently, 
medications that selectively target the serotonin system, such as clomipramine and 
specific serotonin re-uptake inhibitors (SSRls), rank as the most popular and effective 
forms of pharmacological treatment of OCD (Goodman et a l ,  1990; Greist, 1998; 
Jenike, 2004; Micallef and Blin, 2001; Stein, 2002). Clomipramine (Anafranil®) is a
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tricyclic antidepressant that revolutionized the treatment of OCD when introduced. It is 
a potent non-selective 5-HT and noradrenergic re-uptake inhibitor shown to be more 
effective in the decrease of OCD symptoms than previous pharmacologic agents, such 
as monoamine oxidase inhibitors and benzodiazepines (Goodman et al., 1990; Greist, 
1998; Micallef and Blin, 2001). SSRIs such as fluoxetine (Prozac®), paroxetine 
(Paxil®), fluvoxamine (Luvox ®), and sertraline (Zoloft®) have potent efficacy in 
reducing OCD symptoms, while selective noradrenergic re-uptake inhibitors (NSRIs) 
and dopamine antagonists are ineffective (Goodman et al., 1990; Greist, 1998; Micallef 
and Blin, 2001). Desipramine, an antidepressant that is primarily a NSRI, is not 
effective for the treatment of compulsive disorders in humans (Hoehn-Saric, et al., 
2000).
For this model to have good predictive validity, compulsive-like behaviors should be 
attenuated by SSRI treatment and not by NSRI treatment. We examined the effects on 
nest-building o f pharmaceutical manipulations with the SSRI, fluoxetine and the 
tricyclic antidepressant, clomipramine, as well as the NSRI, desipramine. In addition, 
we examined the effects of fluoxetine treatment on an additional compulsive-like 
behavior, digging behavior, as assessed by the marble-burying test.
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2.3. Methods
2.3.1. Assessment o f Compulsive-Like Behaviors
2.3.1.1. The Animals
BIG and SMALL male house mice, Mus musculus, were raised on wood shavings in 
polypropylene cages (27x17x12 cm) under a 12:12 light-dark cycle at 22±1°C. Young 
were weaned at 19-21 days o f age and housed with same-sex littermates until the start 
of the experiment. Food (Purina Mills, Lab Diet Mouse Diet #5015, St. Louis, MO) and 
water were available ad libitum. All animals were approximately 50 days of age at the 
start of each experiment. Animal care and experimental procedures were approved by 
the University of Alaska Fairbanks Institutional Animal Care and Use Committee 
(IACUC #02-57; approved 12-16-02; IACUC #05-64; approved 1-12-06, current).
2.3.1.2. Nest-building Behavior
Mice were housed individually on wood shavings in polypropylene cages (27x17x12 
cm) under a 12:12 light-dark cycle at 22±1°C and provided with a pre-weighed roll of 
cotton (Mountain Mist cotton batting, Troy, Inc., Chicago, Illinois) in the cage-top food 
hopper. Twenty-four hours later the cotton roll was weighed and put back after the nest 
had been removed. Extra cotton was added when necessary. This procedure was 
repeated for an additional 3 days. The total nesting score is defined as the amount of 
cotton used over a 4-day testing period (Bult & Lynch, 1996, 1997, 2000). Nesting 
behavior is quantified by the total nesting score. This test was performed every week for 
the duration of the experiments.
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2.3.1.3. Wheel-Running Behavior
Locomotor activity was quantified following standard protocols (Amy et a l,  2000; 
Castillo et al., 2004; Castillo et a l, 2005; Hochstetler et a l, 2004; Yan et al., 2003). 
Briefly, wheel-running activity of individually housed mice was measured using 24.2­
cm diameter Nalgene running wheels mounted in polycarbonate cages (21x42x20 cm) 
equipped with a magnetic switch and wood shaving bedding. The number of wheel 
revolutions was continuously recorded in 5-min bins by computer with the VitalView 
data collection system (Mini-Mitter Co., Inc., Bend, Oregon).
2.3.1.4. Marble-Burying Behavior
The marble-burying test has been used as an effective model of compulsive-like 
behaviors in mice (Njung’e and Handley, 1991; Gyertyan, 1995; Takeuchi et a l, 2002). 
Mice were placed individually in a polypropylene cage (37x21x14 cm) containing 20 
glass marbles (10mm in diameter) evenly spaced on 5cm-deep sawdust without access 
to food or water for 20 minutes. The number of marbles that were at least 2/3 buried 
within 20 minutes quantified compulsive-like digging activity. After the 20-minute test, 
the animals were returned to their original home cages. This test was performed once a 
week, by an observer blind to the mouse’s nesting phenotype and treatment.
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2.3.1.5. Drug Administration
2.3.1.5.1. Preliminary Fluoxetine and Clomipramine Nesting Study
Mice were housed in a 12:12 light-dark cycle with food and water available ad libitum. 
Animals were tested for drinking behavior for 1 week, prior to preliminary nesting 
measurements. Average daily water consumption was used to calculate appropriate drug 
dosages. The mice were then tested for baseline nest-building behavior for 3 weeks 
prior to drug treatment. Nest-building behavior was tested for 13 weeks; after which the 
drug treatment ended. Post-treatment, mice were tested for an additional 4 weeks. The 
mice were divided into two drug groups (n=16 per group); fluoxetine (5 mg/kg/day) and 
clomipramine (20 mg/kg/day). Drugs were added to the drinking water and available ad 
libitum. After 8 weeks, drug doses were increased: fluoxetine 15 mg/kg and 30mg/kg; 
clomipramine 40 mg/kg and 80mg/kg. The control group received tap water containing 
sucrose (2.9 g/L). Body weight was measured weekly as an indicator of the animals’ 
health.
2.3.1.5.2. Fluoxetine Dose Dependent Nesting Study
Male BIG mice (n=l 1 or 12 per group) were tested for baseline nest-building behavior 
and water consumption (tap water) for 4 weeks prior to drug administration. Fluoxetine 
was orally administered (0, 5, 10, 30, 50, or 100 mg/kg; ProVet, Seattle, WA) for 4 
weeks. Drug treatment was followed by 4 weeks of tap water to test for drug washout 
effects. Controls were given sucrose (2.9 g/L) in tap water.
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2.3.1.5.3. Fluoxetine Wheel-Running Study
Locomotor behavior was assessed using wheel-running activity. Wheel-running 
behavior was used to determine if a change in nest-building behavior was due to a 
general decrease in locomotor activity. Male BIG mice (n= ll or 12 per group) were 
orally treated (in drinking water) with 30 or 80 mg/kg/day of fluoxetine (ProVet, 
Seattle, WA). Locomotor behavior was assessed for 5 weeks prior, 8 weeks during and 
4 weeks post-drug treatment, using average wheel-running activity levels per 5-minute 
bin. Controls were given sucrose (2.9 g/L) in tap water.
2.3.1.5.4. Fluoxetine Marble-Burying Study
Male BIG mice (n= ll or 12 per group) were tested for baseline marble-burying 
behavior for 3 weeks and then orally treated for 4 weeks with fluoxetine (ProVet, 
Seattle, WA)(30 or 80 mg/kg/day) or sucrose vehicle (2.9 g/L, in tap water) in their 
drinking water. Marble-burying was assessed once a week during the treatment period 
and then for 4 weeks post-treatment to test for washout effects.
2.3.1.5.5. Desipramine Nesting Study
Desipramine (Sigma Aldrich Inc., St Louis, MO) (30 mg/kg/day), fluoxetine (ProVet, 
Seattle, WA) (50 mg/kg/day) or sucrose (2.9 g/L, in tap water) were orally administered 
to BIG male mice (n= ll or 12 per group), and dosage was determined as described 
earlier. Nest-building behavior of BIG male mice was recorded for 3 weeks prior to 
drug treatment, 4 weeks during treatment, and 4 weeks after treatment.
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2.3.1.6. Statistical Analyses
Nest-building, wheel-running and marble-burying behavioral data were analyzed by 
repeated-measures ANOVA with time (1-week periods for the entire experiment) and 
drug (and drug dose) effects. The General Linear Models (GLM) procedure also 
included Time x Drug interaction effects. If significant effects were found, pair-wise 
differences were tested for significance using the Tukey Studentized Range Test (Sokal 
and Rohlf, 1981). All statistics were done using SAS software (Version 9.1.3, Cary, 
NC).
2.3.2. Assessment o f Anxiety in Nest-Building Mouse Lines
2.3.2.1. The Animals
A total, 109 adult male mice (3 to 5 months o f age) were used in this study. All animals 
were individually housed in cages (18 x 12 x 13 cm). Animals were maintained in a 
12:12 hr light-dark schedule (lights on at 08:00) in a climate room at 20 ± 0.5 °C. Food 
(Hope Farms® mouse pellets, Woerden, The Netherlands) and water were available ad 
libitum. Principles o f laboratory animal care (NIH publication No. 86-23, revised 1985) 
were followed, and experiments were approved by the Animal Experimentation 
Committee of the University of Groningen (Dec. No. 2091 & 2093).
2.3.2.2. Open Field and Elevated Plus Maze
Twenty mice (10 of each line) were brought to the testing room 24 hours before the 
open field test was performed. All tests took place between 13:00 and 15:00. The open
22
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field (82 cm wide, 32 cm deep) consisted of an inner and outer zone (17 cm distance 
lfom the edge). A 40-Watt light bulb was placed above the open field at a height of 1.4 
m. The animals were placed in the center of the open field for 3 minutes. The behavior 
of the animals was video taped and analyzed with the aid of EthoVision (Noldus, 
Wageningen, The Netherlands). The time taken to leave the center and to reach the 
outer zones (“latency”), and the times spent in the outer and inner zone were measured. 
In addition, number o f rears (standing on hind legs) and the total distance traveled 
through the open field by the subjects were recorded.
Thereafter, these 20 mice were brought to another testing room 3-7 days before the 
elevated plus maze test, an additional test for anxiety in mice, was performed. The plus- 
maze was made o f grey perspex and elevated to a height of 75 cm. It consisted of two 
open arms (30 x 5 cm) and two enclosed arms (30 x 5 cm, with a closed roof). Four 
mm-high ledges surrounded the two open arms. All tests took place between 13:00 and 
15:00, under dim red light to encourage the animals to explore the maze. Each mouse 
was placed in the central square ( 5 x 5  cm) facing an open arm, and allowed to explore 
the maze for 5 minutes. The times spent on the open arms, closed arms and in the center 
were measured as well as the number of entries into a closed arm, into an open arm, and 
total number of entries (Pellow, et al., 1985). An entry was defined as at least three of 
the four paws being on the arm. The maze was cleaned before each test.
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2.3.2.3. Experimentallv-Naive and Experienced Individuals
In this experiment, a group of 10 experimentally-naive individuals (5 of each line) were 
tested in the elevated plus-maze as described above and compared to experimentally- 
experienced individuals to determine whether the previously performed open field test 
described above had influenced the animals’ level o f anxiety/fear as assessed by the 
time spent on specific areas o f the maze.
2.3.2.4. Statistical Analyses
A Mann Whitney U-test (MWU) or a Student’s t-test was used for statistical analysis. In 
addition, in the naive versus experienced experiment, an ANOVA for repeated 
measures was done, in which mouse line was the between-subject factor and block the 
within-subject factor. We used simple contrast, comparing values of each single block 
with the first, to determine interaction effects. Finally, a post-hoc Student’s t-test 
analysis at block 1 was done to compare the initial performance between the lines. A 
probability level of p<0.05 was used as an index of statistical significance in all cases. 
All tests were applied two-tailed, and all data are presented as mean ± standard error of 
the mean (±SEM).
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2.4. Results
2.4.1. Assessment o f Compulsive-Like Behaviors
2.4.1.1. Marble-Burving Behavior
To provide additional face validity for the compulsive-like phenotype o f the BIG mice, 
marble-burying behavior was tested in male BIG and SMALL nest-building mice. 
During a 4-week testing period, male BIG mice buried significantly more marbles than 
male SMALL mice (Fig. 2.2; repeated-measures ANOVA for Line effect: Fi,io=T58.15, 
p<0.0001; Time effect: F4,8o=T .86, p>0.125; Line x Time interaction effect: Fi2,8o= 1.01, 
p>0.447).
2.4.1.2. Clomipramine and Fluoxetine’s Effects on Nest-Building
Fluoxetine and clomipramine reduced compulsive-like nest-building in male BIG mice 
(Fig. 2.3 & 2.4). The mice that received 30 mg/kg/day of fluoxetine and 80 mg/kg/day 
clomipramine had a reduction in nest-building levels (Fig. 2.3; repeated measures 
ANOVA for Drug effect: ¥1,14=4.64, p < 0.049; Fig. 2.4; repeated measures ANOVA 
for Drug effect: Fi,i4=7.53, p < 0.02; respectively). Other drug dosages had no 
significant effect (Fig. 2.5 & 2.6). The drugs had no effect on body weight of the 
treatment groups as compared to controls (data not shown) indicating that the mice did 
not develop the characteristic weight loss associated with serotonin syndrome (Lane and 
Baldwin, 1997). After the drug treatment ended, nesting scores returned to control 
levels in the fluoxetine (30 mg/kg/day) and the clomipramine (80 mg/kg/day) groups 
(Fig. 2.3 & 2.4).
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2.4.1.3. Fluoxetine’s Dose Dependent Effect on Nest-Building
Fluoxetine reduced nest-building behavior in male BIG mice. The 100 mg/kg dose 
showed the largest decrease in nesting behavior (< 40% of pre-drug levels; Fig. 2.7), 
followed by smaller decreases in animals exposed to 50 mg/kg and 30 mg/kg, 
respectively (repeated-measures ANOVA for Dmg effect: Fs;62=2.99, p<0.02; Time 
effect: Fg,558=29.38, p<0.0001; Drug x Time interaction effect: F45,55g=4.92, p<0.0001). 
The 5 mg/kg and 10 mg/kg doses had no effect on the level of nesting behavior 
compared to the control group. All drug-treated mice returned to baseline levels after 4 
weeks without drug treatment (Fig. 2.7). Fluoxetine had no effect on water consumption 
or body weight as compared to the control group (data not shown). The largest effects 
of fluoxetine were not apparent until the end of the treatment period (Fig. 2.7), which is 
similar to the delayed full response in humans (Man et al., 2004).
2.4.1.4. Fluoxetine’s Effect on Wheel-Running
Wheel-running behavior, measured as the average number of wheel revolutions per day 
in 5-minute bins, was not different among drug and control groups (Fig. 2.8; repeated 
measures ANOVA for Drug effect: F|.4o=0.21, p>0.50). All groups of mice (control, 30 
and 80 mg/kg fluoxetine) reduced their average locomotor activity level by 
approximately 50% of pre-drug values towards the end of the drug treatment period 
(repeated measures ANOVA for Time effect (week): Fij4o= 13.28, p<0.0008), which 
may have been due to an age effect or uncontrolled environmental factors such as 
humidity (Lynch, 1992). These results indicate that fluoxetine did not significantly
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decrease activity levels during 8 weeks of drug treatment. Therefore, the decrease in 
nest-building behavior after treatment with 30 and 80mg/kg/day of fluoxetine cannot be 
attributed to a decrease in locomotor activity, but appears to be specific to compulsive­
like nesting behavior. The 100 mg/kg/day dose probably did not result in decreased 
activity levels, although the maximum dose we could test while the animals were using 
the wheels was 80 mg/kg/day, because higher doses resulted in a significant decrease in 
water drinking behavior.
2.4.1.5. Desipramine’s Effect on Nest-Building
Desipramine had no significant effect on nest-building behavior in male BIG nest- 
builders (Fig. 2.9), which is consistent with previous OCD research in humans. A 
significant drug effect (F2,46=7.74; p<0.002), a significant time (week) effect 
(F10,460=2 8.75; p<0.0001), and a significant drug by time interaction effect (F2o,46o=5.58; 
p<0.0001) were found. Desipramine treated mice had no significant difference in 
cotton usage from the control group (Fi;3i=0.43; p>0.50), and desipramine treated mice 
had a significant time (week) effect (F10.31 o==22.22; p<0 .0 0 0 1 ), which may be due to 
uncontrolled environmental factors, such as humidity (Lynch, 1992). Fluoxetine treated 
mice significantly decreased cotton usage as compared to control (Fi,30= 1 6 .01; 
p<0.0005) with significant time (week) (Fio,3oo=20.51; p<0.0001) and drug by time 
(week) interaction (Fio,3oo=10.51; p<0.0001) effects.
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2.4.1.6. Fluoxetine’s Effect on Marble-Burying
In a separate study, male BIG nest-builders were tested for the effects of fluoxetine (30 
mg/kg and 80 mg/kg/day) or sucrose control (2.9 g/L) on marble-burying behavior. 
Male BIG nest-builders significantly reduced their digging behavior by approximately 
half of their pre-drug digging scores with both the 30 and 80 mg/kg doses (Fig. 2.10; 
repeated-measures ANOVA for Drug effect: ¥2,n=2.99, p<0.04; Time effect: 
F10,320=17.38, p<0.0001; Drug x Time interaction effect: F2o,32o=3.78, p<0.0001). The 
two doses did not differ significantly.
2.4.2. Assessment o f Anxiety in Nest-Building Mouse Lines
2.4.2.1. Open Field
Performance in the open field differed significantly between BIG and SMALL nest- 
builders. SMALL mice showed more inhibited exploratory activity and risk assessment 
behavior in the open field. Some SMALL mice typically started exploration of the inner 
zone of the open field by rotating around their hind paws, without moving their hind 
paws from the center area where they were initially placed. Total exploratory activity, 
indicated by the distance traveled in the open field, was two-fold and significantly 
longer in BIG than SMALL mice (Table 2.1; p<0.0001; Student’s t-test). Time taken 
before leaving the center of the open field and to explore the outer zone was longer in 
SMALL than in BIG mice. SMALL mice took almost 10 times longer than BIG mice to 
start exploring the outer zone (Table 2.1; p<0.002; MWU). As a consequence, also the
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times spent in the inner and outer zones differed significantly between the lines (Table 
2.1; p<0.05 and p<0.01, respectively; MWU).
Rearing frequency in the outer zone (peripheral rearing; center rearing was only rarely 
seen, and, if so, in BIG mice only) differed significantly between the lines, with BIG 
mice rearing approximately three times more often than SMALL mice (Table 2.1; 
p<0.01; MWU). The time spent in rearing differed 4-fold and significantly between the 
two lines (Table 2.1, p<0.05; MWU).
2.4.2.2. Elevated Plus Maze Performance
To test whether it was fear-like behavior in the SMALL mice that inhibited exploratory 
behavior and rapid adjustment to a new, unfamiliar environment, an elevated plus-maze 
test was performed on all nest-builders previously tested in the open field (Belzung and 
Griebel, 2001; Parks et al., 1998; Pellow, et al., 1985). However, any degree of fear-like 
behavior in the elevated plus maze may have been influenced, at least in part, by the 
animals' experience with previous exposures to unfamiliar environments. Therefore, a 
second group of 10 experimentally-naive animals (5 of each line) was tested as well. 
Experimentally-experienced SMALL mice showed enhanced exploratory behavior, 
indicated by the significantly higher number of arm entries into the open arm (p<0.04; 
MWU) and total arm entries (p<0.04; MWU) compared to the less experienced SMALL 
mice (Table 2.2). No such differences were observed for BIG mice (Table 2.2). Pooling 
experienced and less experienced mice, the general activity (indicated by the number of
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entries into open and closed arms as well as the total entries) was significantly higher in 
the BIG compared to SMALL mice. The time spent on open or closed arms also 
differed between the lines. SMALL mice spent significantly less time on the open arm 
(p<0.01; MWU), and significantly more time in the closed arm (p<0.05; MWU), 
suggesting that fear/anxiety-like behavior levels were higher in SMALL than in BIG 
nest-builders.
The percent of time spent in open arms (of total time spent in arms) provides an 
additional measure of anxiety-like related behavior (calculated from data obtained from 
Table 2.2) (Belzung and Griebel, 2001; Parks et al., 1998; Pellow, et al., 1985). BIG 
mice spent 23.97 ± 4.18 % of their time in the open arms, but SMALL mice spent 
significantly less time there (7.71 ± 2,43 %; p<0.008; MWU). Also this measure 
revealed the highest fear or anxiety-like behavior in SMALL mice (Belzung and 
Griebel, 2001; Parks et al., 1998; Pellow et al., 1985). For this anxiety measure, no 
significant difference was found between experimentally-experienced and 
experimentally-naive mice.
2.5. Discussion
Both chronic oral fluoxetine and clomipramine treatment reduced compulsive-like nest- 
building behavior in male BIG mice, while desipramine did not significantly alter this 
behavior. Furthermore, chronic oral fluoxetine administration decreased nest-building 
behavior of BIG mice in a dose-dependent manner. Fluoxetine is a commonly
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prescribed serotonin re-uptake inhibitor for the treatment of OCD symptoms in humans 
(Goodman et al., 1990; Greist, 1998; Micallef and Blin, 2001). The latency to peak 
effect found in the present study is also similar to the delayed response of SSRIs in 
human OCD patients (Man, et al., 2004). Importantly, the administration o f fluoxetine 
did not cause a decrease in general locomotor behavior, as assessed by wheel-running 
activity, but appeared specific to the compulsive-like nest-building behavior. Combined, 
these findings suggest that the nest-building phenotype has good predictive validity for 
modeling OCD in humans.
In addition to compulsive-like nest-building, BIG mice also displayed compulsive-like 
digging behavior, as evidenced by the number of marbles buried. In addition, chronic 
oral fluoxetine treatment reduced compulsive-like digging behavior in BIG mice as 
compared to SMALL mice. The marble-burying test has been used to assess 
compulsive-like behaviors in mice (Njung'e and Handley; 1991) using digging, a non­
fear induced behavior. However, Borsini et al. 2002 suggested that marble-burying may 
be a model for anxiety (Borsini et al., 2002). However, the present data obtained from 
two behavioral tests commonly used to assess fear/anxiety-like behavior in rodents, i.e., 
open field and elevated plus maze, suggested otherwise in our mice. These data 
revealed a consistent difference between the selection lines in response to 
environmental challenges. In general, SMALL mice showed more behavioral inhibition 
in response to a novel environment. General activity in a novel environment was 
consistently higher in BIG mice. The behavior shown by SMALL mice in the open field
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and elevated plus-maze, which can be interpreted as (predatory) risk assessment 
behavior and movement inhibition, clearly indicated higher levels of anxiety/fear-like 
behavior (Belzung and Griebel, 2001; Parks et al., 1998; Pellow et al., 1985). In 
summary, behavioral phenotyping indicated that SMALL mice were inhibited in their 
natural tendency to explore a novel environment while BIG mice lacked the inhibition 
to explore an unfamiliar environment. This is consistent with earlier observations that 
BIG mice employed active coping strategies, while SMALL mice used passive coping 
strategies (Sluyter et al., 1995). Taken together, these data support the marble-burying 
as a test for compulsive-like behaviors in these mice, not for anxiety, providing further 
support for the face validity of these mice as a potential animal model of OCD.
The present animal model differs from most other models in the route of drug 
administration. Using an oral delivery of fluoxetine provides advantages, such as a 
similar delivery route as seen in human clinical settings, as well as reduced handling 
and injection stress on the animals. However, due to efficiency in absorption and 
excretion, bioavailability o f fluoxetine after oral administration is much lower than 
through other routes (Caccia et al., 1990). For example, a dose of 10 mg/kg IV produces 
a maximum plasma concentration (Cmax) of 3.8 jxM, whereas the same dose through 
oral administration results in a Cmax of 0.4 pM, or 10% of the IV route (Caccia et al., 
1990). Hence, oral doses need to be higher than those administered through more direct 
routes to compensate for the hepatic first-pass effect (Caccia et al., 1990). This first- 
pass metabolism of fluoxetine by the liver is likely subject to transient saturation with
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increasing doses, thereby producing a complex, nonlinear pharmacokinetic profile 
(Caccia et al., 1990; Altamura et al., 1994). Furthermore, these pharmacologic 
properties of fluoxetine are manifested differently in rodents and in humans (Altamura 
et al., 1994). Hence, care should be taken when extrapolating animal dose-response 
models using fluoxetine to clinical applications. Future studies need to be conducted to 
determine the plasma and brain concentrations o f fluoxetine and its metabolites using 
oral administration in mice.
These nesting mice are a novel spontaneous animal model. The nest-building behavior 
exhibited by these mice has a genetic component in which approximately 30% of the 
variation among individuals in the expression of the behavior can be attributed to 
additive genetic factors, while approximately 70% of the variation is mostly due to 
environmental factors (Bult and Lynch, 2000; Lynch, 1980). OCD in humans also 
appears to have a genetic component as well as environmental components (Hettema et 
a l, 2001). In addition, nesting behavior is a highly polygenic trait (Bult and Lynch, 
2000), which is consistent with OCD in humans likely being influenced by many 
different genes. In twin studies of humans, concordance rates among monozygotic twins 
are generally significantly higher than concordance rates in dizygotic twins (Hettema et 
al., 2001). Familial components in humans have also been identified, including 
increases in prevalence o f OCD among first-degree relatives (Jenike, 2004; Pauls and 
Alsobrook, 1999; Stein, 2002). Several clinical studies have targeted functional genetic 
polymorphisms. For example, OCD patients are more likely to carry 2 copies of a long
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allele for the serotonin transporter (5-HTTLPR) (Bengel et al., 1999). Initial 
investigations of other functional genetic polymorphisms, including catechol-O- 
methyltransferase, monoamine oxidase-A, the 5-HTiDbeta serotonin receptor, and 
dopamine receptors, report an association with OCD (Micallef and Blin, 2001; Stein, 
2002), although inconsistent or non-replicated results indicate a need for further 
investigation. The polygenic basis of the compulsive-like nesting behavior adds 
additional construct validity to the compulsive-like nesting mouse model.
In conclusion, this proposed model is novel in that it is a spontaneous, non-induced 
behavioral model that shows face and predictive validity and could be of great benefit to 
the study of OCD. Once established as an animal model of OCD, the compulsive-like 
nest-building mouse model may be used as a screening tool for drug and therapeutic 
treatments. Through the use of this mouse model to gain insights in the neural 
mechanisms controlling compulsive-like behaviors, the development of effective 
treatments and a potential cure for OCD may be possible.
34
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2.6. Literature Cited
Altamura AC, Moro AR, Percudani M 1994 Clinical pharmacokinetics of fluoxetine. 
Clin Pharmacokinet 26:201-214.
American Psychiatric Association 1994 Diagnostic and statistical manual o f mental 
disorders, 4th ed. Washington, USA: American Psychiatric Press.
Amy SP, Chari R, Bult A 2000 Fos in the suprachiasmatic nucleus o f house mouse lines 
that reveal a different phase-delay response to the same light pulse. J Biol Rhythms 
15:95-102.
Belzung C, Griebel G 2001 Measuring normal and pathological anxiety-like behaviour 
in mice: a review. Behav Brain Res 125:141-149.
Bengel D, Greenberg BD, Cora-Locatelli G, Altemus M, Heils A, Li Q, Murphy DL 
1999 Association of the serotonin transporter promoter regulatory region 
polymorphism and obsessive-compulsive disorder. Mol Psychiatry 4:463-466.
Borsini F, Podhorna J, Marazziti D 2002 Do animal models o f anxiety predict 
anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163:121-141.
Bult A, Lynch CB 1996 Multiple selection responses in house mice bi-directionally 
selected for thermoregulatory nest-building behavior: crosses of replicate lines. Behav 
Genet 26:439-446.
Bult A, Lynch CB 1997 Nesting and Fitness: Lifetime reproductive success in house 
mice bi-directionally selected for thermoregulatory nest-building behavior. Behav 
Genet 27:231-240.
35
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Bult A, Lynch CB 2000 Breaking through artificial selection limits of an adaptive 
behavior in mice and the consequences for correlated responses. Behav Genet 30:193­
206.
Caccia S, Cappi M, Fracasso C, Garattini S 1990 Influence of dose and route of 
administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. 
Psychopharmacology (Berl) 100:509-514.
Campbell KM, de Lecea L, Severynse DM, Caron MG, McGrath MJ, Sparber SB, Sun 
LY, Burton FH 1999 OCD-like behaviors caused by a neuropotentiating transgene 
targeted to cortical and limbic D1+ neurons. J Neurosci 19:5044-5053.
Castillo MR, Hochstetler KJ, Tavemier RJ Jr, Greene DM, Bult-Ito A 2004 Entrainment 
of the master circadian clock by scheduled feeding. Am J Physiol 287:R551-R555.
Castillo MR, Hochstetler KJ, Greene DM, Firmin SI, Tavernier RJ, Raap DK, Bult-Ito 
A 2005 Circadian rhythm of core body temperature in two laboratory mouse lines. 
Physiol Behav, 86: 538-45.
Demeulemeester H, Feys H, Goris I, Zwaenepoel I, de Weerdt W, de Sutter P, Gybels J, 
Piets C, Nuttin B 2001 Effect of the serotonin agonist 8-OH-DPAT on the 
sensorimotor system of the rat. Pharmacol Biochem Behav 70:95-103.
D’haenen H, Andrews JS 2000 Animal models o f affective disorders. Neuro Res Comm 
26:289-298.
Dodman NH, Moon-Faneli A, Mertens PA, Stein DJ 1997 Animal models of obsessive 
compulsive disorder. In: Hollander E, Stein DJ (eds). Obsessive Compulsive 
Disorders: Diagnosis, Etiology, Treatment. New York: Marcel Dekker 99-144.
36
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Goldberg E, Rapoport JL 1991 Canine acral lick dermatitis: response to anti-obsessional 
drug clomipramine. J Am Anim Hosp Assoc 22:179-182.
Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen 
SA, Heninger GR, Charney DS 1990 Specificity of serotonin re-uptake inhibitors in 
the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 47:577-585.
Greist JH 1998 The comparative effectiveness of treatments for obsessive-compulsive 
disorder. Bulletin of the Menninger Clinic 62: A65-A81.
Gyertyan I 1995 Analysis of the marble burying response: marbles serve to measure 
digging rather than evoke burying. Behav Pharmacol 6:24-31.
Heisler LK, Tecott LH 1999 Knockout corner: neurobehavioural consequences of a 
serotonin 5-HT2Creceptor gene mutation. Int J Neuropsychopharm 2:67-69.
Hettema JM, Neale MC, Kendler KS 2001 A Review and Meta-Analysis o f the Genetic 
Epidemiology of Anxiety Disorders Am J Psychiatry 158:1568.
Hochstetler KJ, Garland T Jr, Swallow JG, Carter PA, Bult-Ito A 2004 Number of 
arginine-vasopressin neurons in the suprachiasmatic nuclei is not related to level or 
circadian characteristics of wheel-running activity in house mice. Behav Genet 
34:131-136.
Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, McElroy S, Zajecka 
J, Chapman D, Clary C, Harrison W 2000 Multicenter Double-blind Comparison of 
Sertraline and Desipramine for Concurrent Obsessive-Compulsive and Major 
Depressive Disorders. Arch Gen Psychiatry. 2000;57:76-82.
Jenike MA 2004 Obsessive-compulsive disorder. N Engl J Med 350:259-265.
37
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Joel D, Avisar A 2001 Excessive lever pressing following post-training signal 
attenuation in rats: A possible animal model o f obsessive-compulsive disorder? Behav 
Brain Res 123:77-87.
Joel D, Doljansky J, Schiller D 2005 “ Compulsive” lever pressing in rats is enhanced 
following lesions to the orbital cortex, but not to the basolateral nucleus of the 
amygdale or to the dorsal medial prefrontal cortex. Eur J Neurosci 21:2252—62.
Korff S, Harvey BH 2006 Animal Models of Obsessive-Compulsive Disorder: 
Rationale to Understanding Psychobiology and Pharmacology. BPharm Psychiatr Clin 
N Am 29:371-390.
Lane R, Baldwin D 1997 Selective serotonin re-uptake inhibitor-induced serotonin 
syndrome: review. J Clin Psychopharmacol 17: 208-221.
Lynch CB 1980 Response to divergent selection for nesting behavior in Mus musculus. 
Genetics 96:757-765.
Lynch CB 1992 Clinal Variation in Cold Adaptation in Mus domesticus: Verification of 
Predictions from Laboratory Populations. The American Naturalist 139:1219-1236.
Man J, Hudson AL, Ashton D, Nutt DJ 2004 Animal models for obsessive-compulsive 
disorder. Current Neuropharm 2:169-181.
McGrath MJ, Campbell KM, Burton FH 1999 The role of cognitive and affective 
processing in a transgenic mouse model of cortical-limbic neuropotentiated 
compulsive behavior. Behav Neurosci 6:1249-1256.
McKinney WT, Bunney WE 1969 Animal models of depression. I. Review of the 
evidence: implications for research. Arch Gen Psychiatry 21:240-8.
38
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Micallef J, Blin O 2001 Neurobiology and clinical pharmacology of obsessive- 
compulsive disorder. Clin Neuropharm 24: 191-207.
Njung'e K, Handley SL 1991 Effects of 5-HT uptake inhibitors, agonists and 
antagonists on the burying of harmless objects by mice; a putative test for anxiolytic 
agents. Br J Pharmacol 104:105-12.
Nordstrom EJ, Burton FH 2002 A transgenic model of comorbid Tourette’s syndrome 
and obsessive-compulsive disorder circuitry. Mol Psychiatry 7:617-625.
Overall KL 2000 Natural animal models o f human psychiatric conditions: assessment of 
mechanisms and validity. Prog Neuropsychopharmacol Biol Psychiatry 24:727- 76.
Parks CL, Robinson PS, Sibille E, Shenk T, Toth M 1998 Increased anxiety of mice 
lacking the serotoniniA receptor. Genetics 95:10734-10739.
Pauls DL, Alsobrook JP II 1999 The inheritance of obsessive-compulsive disorder. 
Child Adol Psychiatry 8:481-496.
Pellow S, Chopin P, File SE, Briley M 1985 Validation of openxlosed arm entries in an 
elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-67.
Rapoport J, Ryland D, Kriete M 1992 Drug treatment of canine acral lick: an animal 
model o f obsessive-compulsive disorder. Arch Gen Psychiatry 49:517-521.
Ricciardi JN, Hurley J 1990 Development of animal models of obsessive-compulsive 
disorders. In: Jenike MA, Baer L, Minichiello WE, editors. Obsessive-compulsive 
disorders: theory and management. Chicago: Year Book Medical Publishers; 1990, pp 
189-199.
39
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Sluyter F, Bult A, Lynch CB, Van Oortmerssen GA, Koolhaas JM 1995 A comparison 
between house mouse lines selected for attack latency or nest-building: evidence for a 
genetic basis of alternative behavioral strategies. Behav Genet 25, 247-252.
Sokal RR, Rohlf FJ 1981 Biometry. W.H. Freeman and Company, New York.
Stein DJ, Shoulberg N, Helton K, Hollander E 1992 The neuroethological model of 
obsessive-compulsive disorder. Comp Psychiatry 33:274-281.
Stein DJ, Dodman NH, Borhelt P, Hollander E 1994 Behavioral disorders in veterinary 
practice: relevance to psychiatry. Compr Psychiatry 35: 275-85.
Stein DJ, Mendelsohn I, Potocnik F, van Kradneberg J, Wessels C 1998 Use of the 
selective serotonin re-uptake inhibitor citalopram in a possible animal analogue of 
obsessive-compulsive disorder. Depression and Anxiety 8:39-42.
Stein DJ 2002 Obsessive-compulsive disorder. Lancet 360:397-405.
Szechtman H, Sulis W, Eilam D 1998 Quinpirole induces compulsive checking 
behavior in rats: a potential animal model o f obsessive-compulsive disorder (OCD). 
Behav Neurosci 112:1475-1485.
Szechtman H, Culver K, Eilam D 1999 Role of dopamine systems in obsessive- 
compulsive disorders (OCD): implications from a novel psychostimulant-induced 
animal model. Polish J Pharmacol 51:55-61.
Szechtman H, Eckert MJ, Tse WS, Boersma JT, Bonura CA, McClelland JZ, Culver KE 
Eilam D 2001 Compulsive checking behavior of quinpirole-sensitised rats as an 
animal model of obsessive-compulsive disorder (OCD): form and control. BMC 
Neurosci 2:4.
40
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Takeuchi H, Yatsugi S, Yamaguchi T 2002 Effect of YM992, a novel antidepressant 
with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic 
activity, on a marble-burying behavior test as an obsessive-compulsive disorder 
model. Japanese J Pharmacol 90:197-200.
Tecott LH, Abdallah L 2003 Mouse genetic approaches to feeding regulation: serotonin 
5-HT2C receptor mutant mice. CNS Spectr 8:578-588.
Van Kuyck K, Demeulemeester H, Feys H, de Weerdt W, Dewil M, Tousseyn T, de 
Sutter P, Gybels J, Bogaerts K, Dom R, Nuttin B 2003 Effects of electrical 
stimulation or lesion in nucleus accumbens on the behaviour of rats in a T-maze after 
administration of8-OH-DPAT or vehicle. Behav Brain Res 140:165-173.
Wilner P 1991 Behavioral models in psycopharmacology. In: Wilner P, editor. 
Behavioral models in psychopharmacology: theoretical, industrial and clinical 
perspectives. Cambridge: Cambridge University Press, pp 3-18.
Yan L, Hochstetler KJ, Silver R, Bult-Ito A. 2003 Relationship between Phase Shifts 
and Per Gene Expression in Mouse Suprachiasmatic Nucleus. NeuroReport 14:1247­
1251.
41
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 2.1. Open field behavior of SMALL and BIG m ice.a n=8; two SMALL mice 
could not be traced by EthoVision for determination of distance traveled. Significance 
are indicated *p<0.05, **p<0.01, ***p<0.0001. All values are expressed as ± SEM
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Small nest-builders 
(n -  10)
Big nest-builders 
(n=  10)
Time (s) to leave inner zone (latency) 48.8 ± 17.5** 5.0 ±1.3
Time (s) spent in inner zone 58.6 ± 19.0* 13.2 ±2.8
Time (s) spent in outer zone 126.8 ± 18.8** 147.2 ±2.5
Number of rears in outer zone 2.6 ± 1.0** 9.3 ± 1.7
Time (s) spent with rearing 4.5 ± 1.9* 17.0 ±2.7
Distance traveled (cm) 1163.7 ± 151.9***a 2270.7 ± 180.5
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Table 2.2. Impact of a previous behavioral test on elevated plus maze 
performance: within-selection-line comparison. Significance are indicated * p<0.05; 
¥ p=0.0576. All values are expressed as ±SEM.
Small nest-builders Big nest-builders
Experimentally
experienced
(n=10)
Experimentally
naive
(n=5)
Experimentally 
experienced 
(n= 10)
Experimentally
naive
(n=5)
Total arm entries 15.8 ±3.1 6.6 ± 1.9* 22.8 ±4.0 23.4 ±2.7
Closed arm entries 12.1 ±2.4 5.8 ± 1.7¥ 15.9 ±2.6 14.8 ±2.3
Open arm entries 3.7 ± 1.1 0.8 ±0.9* 6.9 ±2.1 8.6 ±3.1
Time in center (s) 65.9 ± 12.3 41.6 ± 12.7 59.9 ±9.7 80.8 ± 8.7
Time in closed arm
(s)
212.0 ± 13.7 247.5 ± 18.8 189.3 ± 17.6 160.7 ±27.7
Time in open arm
(s)
22.2 ± 7.3 10.7 ± 12.0 50.8 ± 10.9 58.2 ± 19.6
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
44
GENERATION OF SELECTION
Figure 2.1. Nesting behavior of bi-directionally selected mice. A. The average total 
nesting scores of two replicate lines of the least-square means o f females and males of 
the BIG, CONTROL, and SMALL mice in relation to the generation of selection. B. 
Representative examples of nests built over a 24-hour period by a BIG (left) and 
SMALL (right) mouse with equal access to cotton.
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Figure 2.2. Marble-burying behavior of BIG and SMALL male mice. All
significant differences are indicated *p<0.05, Tukey. Means (± SEM) are shown.
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Figure 2.3. The effects of fluoxetine treatment on compulsive-like nest-building 
behavior of male BIG mice. The data are expressed as a percent of the average of pre­
drug week 3 for each drug and control group so that the groups could be directly 
compared. Significant differences from the control group are indicated *p<0.05, Tukey. 
Means (± SEM) are shown.
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Weeks
Figure 2.4. The effects of clomipramine treatment on compulsive-like nest-building 
behavior of male BIG mice. The data are expressed as a percent of the average of pre­
drug week 3 for each drug and control group so that the groups could be directly 
compared. Significant differences from the control group are indicated *p<0.05, Tukey. 
Means (± SEM) are shown.
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Figure 2.5. The effects of 5 and 15 mg/kg fluoxetine on compulsive-like nest- 
building in male BIG mice.. The data are expressed as a percent of the average o f pre­
drug week 3 for each drug and control group so that the groups could be directly 
compared. Means (± SEM) are shown.
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Figure 2.6. The effects of 20 and 40 mg/kg of clomipramine on compulsive-like 
nest-building behavior in male BIG mice. The data are expressed as a percent of the 
average o f pre-drug weeks 2 and 3 for each drug and control group so that the groups 
could be directly compared. Means (± SEM) are shown.
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Figure 2.7. The effects of fluoxetine treatment on nest-building behavior in male 
BIG mice. The data are expressed as a percent of the average o f pre-drug weeks 3 and 4 
for each drug and control group so that the groups could be directly compared. 
Significant differences from the control group are indicated *p<0.05, Tukey. Means (± 
SEM) are shown.
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Figure 2.8. The effects of fluoxetine on locomotor behavior of BIG male mice.
‘0’ indicates the average of weeks 2-5 prior to drug treatment, all other weeks are 
normalized using this average. Means (±SEM) are shown.
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Figure 2.9. The effects of desipramine and fluoxetine on nest-building behavior in 
BIG male mice. The behavioral expression in the last 2 weeks of the pre-drug period 
was set to 100% for each drug group so that the groups could be directly compared. 
Significant differences from the control group are indicated *p<0.05, Tukey. Means (± 
SEM) are shown.
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Figure 2.10. The effects of fluoxetine treatment on marble-burying behavior in 
BIG male mice. Significant differences from the control group are indicated *p<0.05- 
Tukey. Means (± SEM) are shown.
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The Effects of Fluoxetine and Clomipramine on Female Mice Bi-directionally 
Selected for Nest-Building Behavior, Implications for a Model of Obsessive-
Compulsive Disorder*
3.1. Abstract
Previously, we have used male mice, Mus musculus that exhibit high levels of 
compulsive-like nest-building behavior as a potential model of human obsessive- 
compulsive disorder (OCD). The big nest-building (BIG) male mice have been shown 
to have good face and predictive validity for modeling human OCD. In this study, we 
examined the effects of clomipramine on compulsive-like nest-building behavior in 
female BIG mice. Additionally, we investigated the effects of fluoxetine on marble- 
burying behavior in male and female BIG mice. The studies described here are aimed at 
further validating compulsive-like nest-building mice as a model of human OCD. 
Similar to BIG male mice, female BIG mice exhibited compulsive-like nest-building 
behavior and compulsive-like marble-burying behavior. No gender-related differences 
were found in base-line marble-burying behavior of male and female mice, which is in 
contrast to the gender differences seen in nest-building behavior, where BIG males 
consistently made larger nests than BIG females. Chronic oral fluoxetine treatment 
reduced compulsive-like marble-burying behavior in male BIG mice. The female mice 
did reduce compulsive-like digging; however, this reduction did not reach significance.
* In preparation for the Journal of Pharmacology and Experimental Therapeutics 
DM Greene, DK Raap, H Foltz, M Slater, A Bult-Ito
CHAPTER 3
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Interestingly, fluoxetine affected male and female BIG mice differently, with the BIG 
female mice reaching a plateau by week 3 and 4 of drug treatment and the males still 
decreasing digging behavior after 4 weeks of treatment. Female and male mice differed 
dramatically in their response to the OCD drug clomipramine. Clomipramine did not 
significantly reduce nest-building in female BIG mice, which is in contrast to the 
reduction seen in BIG male mice treated with clomipramine (80 mg/kg/day). In 
conclusion, these findings suggest that the nest-building phenotype has good face 
validity for modeling OCD in humans. These data also demonstrate the importance of 
considering gender-related differences when using animals to model psychiatric 
diseases.
3.2. Introduction
Obsessive-compulsive disorder (OCD) is a psychiatric disorder that involves intrusive 
and unwanted thoughts, ideas, or images (obsessions) that lead to increased anxiety, and 
repetitious, intentional rituals (compulsions) performed in order to neutralize the 
anxiety (DSM-IV, American Psychiatric Association, 1994). The neural mechanisms 
that control OCD are poorly understood due to the paucity of animal models available 
that reveal consistent and spontaneous (non drug-induced or non behaviorally-induced) 
differences in compulsive-like behaviors. Previously, we have used male mice, Mus 
musculus, which exhibit high levels of compulsive-like nest-building behavior, as a 
possible model of OCD in humans (See Chapter 2).
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The OCD mouse model uses mouse lines which have a stable and spontaneous nesting 
phenotype. The nest-building mouse lines exhibit a 40-fold difference between big 
(BIG) and small (SMALL) nest-building mice in the amount of cotton used for a nest 
(see Chapter 2; Bult and Lynch, 1996, 1997, 2000; Lynch, 1980). Interestingly, male 
BIG mice exhibit 20-40% higher levels of compulsive-like nest-building behavior than 
BIG females, which may be due to differences in body weight or other factors (Bult and 
Lynch, 2000). The differences between female and male mice in compulsive-like 
nesting are interesting, and may mirror gender differences seen in the qualitative 
expression of OCD symptoms in humans (Abramowitz et al., 2003; Baer, 1993; 
Bogetto et al., 1999; Buttolph and Holland, 1990; Camarena, et al., 2001; Maina et al., 
1999; Mundo et al., 1999; Stein, 2002; Weissman et al., 1994; Williams and Koran, 
1997; Zohar, Gross-Isseroffb et al., 1999; Zohar, Hermesh et al., 1999).
Medication that selectively targets the serotonin system (e.g., specific serotonin re­
uptake inhibitors (SSRIs) such as fluoxetine, paroxetine, fluvoxamine, and sertraline 
and the tricyclic antidepressant clomipramine) has been used in the successful 
pharmacotherapy of OCD (Goodman et al., 1990; Greist, 1998; Micallef and Blin, 
2001). In this study, we examined the effects on nest-building, in female BIG mice, of 
treatment with clomipramine, a drug commonly effective for the treatment of OCD in 
humans. Additionally, we investigated the effects of fluoxetine on marble-burying 
behaviors in BIG nest-building male and female mice. Marble burying has been used to
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model compulsive behaviors in previous studies (e.g., compulsive-like digging) 
(Gyertyan, 1995; Njung’e and Handley, 1991; Takcuchi et al., 2002).
The studies described here are aimed at further validation of the compulsive-like nest- 
building mice as a model o f human OCD. Gender-based differences have been reported 
for several psychiatric disorders, including OCD (Camarena et al., 2001, Chamey et a l, 
1988; Mundo et al., 1999) so it is important to consider gender when using other 
animals to model OCD in humans. These studies strive to further elucidate any possible 
sex differences that may exist in compulsive-like behaviors and their treatment and lend 
additional face and predictive validity to the compulsive-like nest-building mouse 
model.
3.3. Methods
3.3.1. The Animals
Female and male house mice, Mus musculus, were raised on wood shavings in 
polypropylene cages (27x17x12 cm) under a 12:12 hour light-dark cycle at 22±1°C. 
Young were weaned at 19-21 days of age and housed with same-sex littermates until the 
start of the experiment. Food (Purina Mills, Lab Diet Mouse Diet #5015, St. Louis, 
MO) and water were available ad libitum. All animals were approximately 50 days of 
age at the start of each experiment. Animal care and experimental procedures were 
approved by the University o f Alaska Fairbanks Institutional Animal Care and Use
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Committee (IACUC #02-57; approved 12-16-02; IACUC #05-64; approved 1-12-06, 
current).
3.3.2. Nest-Building Behavior
Mice were provided with a roll of cotton (Mountain Mist cotton batting, Troy, Inc., 
Chicago, Illinois) in the cage-top food hopper. Twenty-four hours later the cotton roll 
was weighed and put back after the nest had been removed. Extra cotton was added 
when necessary. This procedure was repeated for an additional 3 days. The total nesting 
score is defined as the amount of cotton used over a 4-day testing period (Bult & Lynch, 
1996, 1997, 2000). This test was performed weekly for the duration of the experiments.
3.3.3. Marble-Burving Behavior
The marble-burying test has been used as an effective model of compulsive-like 
behaviors in mice (Gyertyan, 1995; Njung’e and Handley, 1991; Takeuchi et al., 2002). 
Mice were placed individually in a polypropylene cage (37x21x14 cm) containing 20 
glass marbles (10 mm in diameter) evenly spaced on 5 cm-deep sawdust without access 
to food or water for 20 minutes. The number of marbles that were at least 2/3 buried 
within 20 minutes quantified repetitive digging activity. After the 20-minute test, the 
animals were returned to their original home cages. This test was performed once a 
week, by an observer blind to the mouse’s nesting phenotype and treatment.
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3.3.4. Drug Administration
3.3.4.1. Clomipramine’s Effect on Nest-Building
After 4 weeks on tap water to obtain baseline levels of repetitive nesting behavior and 
water consumption, female BIG mice (n= ll or 12 per group) were exposed to 40, 50, 
65, 80 or 100 mg/kg/day oral clomipramine (Sigma Aldrich Inc., St Louis, MO) for 6 
weeks. This was followed by 2 weeks of tap water to test for drug washout effects. 
Controls were given sucrose (2.9 g/L) in tap water.
3.3.4.2. Fluoxetine Marble-Burying Study
Female and male BIG mice (n= ll or 12 per group) were tested for baseline marble- 
burying behavior for 3 weeks and then orally treated for 6 weeks with fluoxetine 
(ProVet, Seattle, WA) (30 mg/kg/day or 80 mg/kg/day) or sucrose control (2.9 g/L, in 
tap water) in their drinking water. Marble-burying was assessed once a week during the 
treatment period and then for 4 weeks post-treatment to test for washout effects.
3.3.5. Statistical Analyses
Nest-building and marble-burying behavioral data were analyzed by repeated-measures 
ANOVA with time (1-week periods for the entire experiment) and drug (control and 
drug dose(s)) effects. The General Linear Models (GLM) procedure also included Time 
x Drug interaction effects. If significant effects were found, pair-wise differences were 
tested for significance using the Tukey Studentized Range Test (Sokal and Rohlf, 
1981). All statistics were done using SAS software (Version 9.1.3, Cary, NC).
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3.4. Results
3.4.1. Marble-Burying Behavior
To provide additional face validity for the compulsive-like phenotype of the female BIG 
mice, marble-burying behavior was tested in BIG and SMALL nest-building mice, in 
addition male mice were tested to determine if any sex-related differences were present. 
No significant differences between male and female mice were found in the number of 
marbles buried in a 20-min period (Fig. 3.1; repeated-measures ANOVA for Sex effect: 
F ij4o= 0.01 , p>0.90). Female BIG mice buried significantly more marbles than female 
SMALL mice (Fig. 3.1; repeated-measures ANOVA for Line effect: F3>40=:6.54, 
p<0.002) and BIG male mice buried significantly more marbles than SMALL males 
(Chapter 2).
3.4.2. Fluoxetine’s Effect on Marble-Burving
Female BIG nest-builders were tested for the effects of fluoxetine (30 and 80 
mg/kg/day) or sucrose vehicle (2.9 g/L) on marble-burying behavior. Female BIG nest- 
builders in the 80 mg/kg drug group reduced their digging behavior from approximately 
20 marbles buried to approximately 13 marbles buried. However, this reduction was not 
significant (Fig. 3.2 and 3.3; repeated-measures ANOVA for Drug effect: F2,33=2 .38, 
p>0.45; Time (week) effect: Fi0,330=16.37, p<0.0001). A significant drug by time 
(week) interaction effect was found (Drug x Time interaction effect: F2o,33o=2.61, 
p<0.004). A sex effect in fluoxetine treatment response on marble-burying behavior was 
not significant, but the time by sex interaction effect was significant (repeated-measures
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ANOVA for Sex effect: Fi,65=2.47, p>0.10; Time x Sex interaction effect: Fio/,5o=4 .0 0 , 
p<0.0001), indicating a difference in treatment response between male and female BIG 
mice over time (Fig. 3.3).
3.4.3. Clomipramine’s Effect on Nest-Building
Clomipramine treatment did not significantly reduce nest-building behavior in female 
BIG mice (Fig. 3.4; repeated-measures ANOVA for Drug effect: F5/,o=0.96, p>0.45; 
Time effect: Fn,660=4.98, p<0.0001; Drug x Time interaction effect: F55,660=0.94, 
p>0.59). A significant time effect was found, which may be due to a change in humidity 
or other uncontrolled environmental factors (Lynch, 1992).
3.5. Discussion
Female BIG mice exhibited compulsive-like nest-building behavior and digging 
behavior, providing additional face validity for the compulsive-like nest-building 
model. Interestingly, a gender difference was found in the treatment response of 
fluoxetine’s effect on compulsive-like digging behavior. BIG female mice reached a 
plateau in treatment response by week 3 and 4 of drug treatment while male BIG mice 
were still decreasing digging behavior after 4 weeks of treatment. In addition to the 
difference in treatment response to fluoxetine, female and male BIG mice differed in 
their response to the OCD drug clomipramine. Clomipramine did not significantly 
reduce nest-building in female BIG mice, which is in contrast to the decrease seen in 
BIG male mice treated with clomipramine (80 mg/kg/day; see Chapter 2).
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Gender differences have been reported in treatment response in OCD patients 
(Camarena et al., 2001, Chamey et al., 1988; Mundo et al., 1999). Camarena et al. 
(2001) reported a possible beneficial effect of monoamine oxidase A (MAO-A) 
inhibitors in a particular subtype o f OCD females due to allelic differences between 
OCD male and female patients in the MAO-A gene. Mundo et al. (1999) also found that 
after an acute intravenous clomipramine infusion, males experienced an increase in 
obsessions and a poorer response to chronic treatment with SSRIs than female patients. 
While the quantitative expression among females and males is similar, some gender- 
related qualitative differences associated with OCD have been shown (Zohar, Gross- 
Isseroffb et al., 1999; Zohar, Hermesh et a l, 1999). Males tend to have an earlier age of 
onset than females (Bogetto et al., 1999; Mundo et al., 1999; Stein, 2002; Weissman et 
al., 1994). Furthermore, onset is more likely to be experientially-related in females 
(e.g., by a traumatic occurance or life events such as pregnancy) (Abramowitz et al., 
2003; Bogetto et al., 1999; Buttolph and Holland., 1990; Maina et a l, 1999; Williams 
and Koran, 1997). Female OCD patients, in general, tend to have more aggression and 
contamination obsessions and cleaning rituals, while males tend to have a higher 
frequency of sexual, exactness, and symmetry obsessions and odd rituals (Baer, 1993; 
Bogetto et al., 1999, Camarena et al., 2001). In humans, gonadal hormone influences 
during development have been suggested to contribute to differential onset and 
expression of anxiety disorders (including OCD) in females and males (Borisova et al., 
1996; Cloitre et al., 2004; Cowbum and Payne, 1994; Zhang et al., 1997). The gender
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differences in compulsive-like nest-building behavior between BIG male and female 
mice may be homologous to those seen between male and female OCD patients.
Gender-related treatment differences have also been reported in other serotonin 
dysfunction related disorders, such as unipolar depression, where men responded more 
positively to the tricyclic antidepressant imipramine than women (Lewis-Hall et al., 
1997; Schneider et al., 1997; Wolk & Weissman, 1995). Women with depression also 
responded significantly better to SSRIs than to imipramine, whereas men responded 
significantly better to imipramine than to SSRIs (Steiner et al., 1990; Komstein et al.,
2000) Additionally, in patients with atypical depression and associated panic attacks, 
women had a more positive response to MAO-A inhibitors than to tricyclic 
antidepressants while men responded more favorably to tricyclics (Wilson et al., 1989; 
Camarena et al., 2001).
Interestingly, gender differences in treatment response have also been observed in some 
animal models of OCD. Recently, Agrati et al. (2005) found that the reproductive stage 
of the female rats influences the induction o f compulsive-like behavior in an 8-OH- 
DPAT based OCD model. Compulsive-like behavior has also been found to differ 
between sexes in prepubertal rats, e.g., spontaneous alternation, differed between male 
and female young rats, 8-OH-DPAT administration induced perseverance of 
compulsive-like behaviors in males but not in females (Ulloaa et al., 2004). These 
differential response patterns suggest that gender should be an important consideration
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when using other animals to model OCD in humans.
In conclusion, in combination with the data from the male BIG nest-building mice (See 
Chapter 2), these findings suggest that the nest-building phenotype has good face 
validity for modeling OCD in humans. These data also demonstrate the importance of 
considering gender-related differences when using animals to model psychiatric 
diseases. Research is ongoing to determine what neurobio logical differences are present 
between the male and female BIG mice, especially in brain areas and receptors that 
have been implicated in the neurobiology o f human OCD patients. Once these mouse 
lines are established as an animal model o f OCD, the development of the nesting mice 
as a screening tool for drug and therapeutic development may then be possible. This 
mouse model could potentially be used to gain knowledge about the neural mechanisms 
controlling compulsive-like behaviors, how they differ between males and females and 
potentially lead to the development of effective gender-specific treatments.
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Figure 3.1. Marble-burying behavior in female and male BIG and SMALL mice.
All significant differences are shown *p<0.05, Tukey. Means (± SEM) are shown.
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Figure 3.2. The effects of fluoxetine on marble-burying behavior in female BIG 
mice. Means (± SEM) are shown.
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Figure 3.3. A comparison of the effects of fluoxetine on marble-burying behavior 
of female and male BIG mice. Means (± SEM) are shown.
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Figure 3.4. The effects of clomipramine on nest-building behavior of female BIG 
mice. The drug groups were normalized as a percent of the average pre-drug nest- 
building of weeks 3 through 4. Means (± SEM) are shown.
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CHAPTER 4 
The Effects of Serotonergic Lesions of the Dorsal Raphe Nuclei on Compulsive-like 
Nest-Building Behavior in Mice*
4.1. Abstract
Obsessive-compulsive disorder (OCD) affects approximately 2% of the adult human 
population to the extent that it causes significant impairment in daily life tasks. The 
essential features of OCD are recurrent obsessions and compulsions, such as doubting, 
checking, and washing. The neural mechanisms that control OCD are poorly understood 
due to the lack of consistent and spontaneous animal models. We have proposed that 
house mice, Mus musculus, bidirectionally selected for high (BIG) and low (SMALL) 
levels o f compulsive-like nesting behavior as an animal model of human OCD. In 
addition to the compulsive-like phenotype of the nest-building mice, the BIG and 
SMALL mice also differ in circadian rhythm organization, such as in their response to 
light pulses and in their activity profiles of wheel-running behavior (wheel revolutions). 
The suprachiasmatic nuclei (SCN; the master circadian clock) receive extensive 
serotonergic innervation from the raphe nuclei. Importantly, the raphe nuclei also send 
serotonergic projections to cortical and striatal regions associated with OCD. Serotonin 
(5-HT) has been found to be involved in modulating circadian rhythms as well as in the 
pathogenesis and treatment of OCD. To test whether 5-HT pathways extending from the 
dorsal raphe nucleus are involved in compulsive-like nest-building behavior, mice
* In preparation for the Journal of Pharmacology and Experimental Therapeutics 
DM Greene, MR Castillo, H Sangha, KA Alexander, A McMahan, A Bult-Ito
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received indirect (via the third ventricle) or direct serotonergic lesions of the dorsal 
raphe nucleus. BIG mice that received serotonergic lesions of the dorsal raphe nucleus 
had a significant reduction in compulsive-like nest-building behavior. These data 
indicate that the dorsal raphe nucleus is involved in the regulation of compulsive-like 
nest-building behavior.
4.2. Introduction
Obsessive-compulsive disorder (OCD) affects approximately 2% of the adult human 
population to the extent that it causes significant impairment in daily life tasks (Man et 
al., 2004). The essential features of OCD are recurrent obsessions and compulsions, 
such as doubting, checking, and washing (DSM-IV, American Psychiatric Association, 
1994). The neural mechanisms that control OCD are poorly understood due in part to 
the paucity o f appropriate animal models. In order to further elucidate the neural 
mechanisms underlying OCD an animal model must have construct validity as well as 
face and predictive validity.
Mice (Mus musculus) bi-directionally selected for levels nest-building behavior (BIG 
and SMALL mice) exhibit a 40-fold difference in the amount of cotton collected in the 
cage (See Chapter 2; Bult and Lynch 1996, 1997, 2000). BIG mice interact with the 
cotton for nest-building by using repetitive motions of the forelimbs and mouth, 
indicating good face validity with compulsive behaviors seen in human OCD patients 
(See Chapter 2).
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Selective serotonin (5-HT) re-uptake inhibitors (SSRIs) represent some of the most 
effective treatments of OCD symptoms (Goodman et a l, 1990; Greist, 1998; Jenike, 
2004; Micallef and Blin, 2001; Stein, 2002). Why OCD patients are responsive to SSRI 
treatment is still unknown, but this finding has led to the premise that the 5-HT system 
in the brain is involved in OCD. Recent findings in compulsive-like nest-building mice 
have shown that the SSRI fluoxetine and the tricyclic antidepressant clomipramine, 
which are effective in reducing OCD symptoms in humans, attenuated compulsive-like 
nest-building behavior in BIG mice, indicating serotonergic pathway involvement in 
compulsive-like nest-building and predictive validity of this model (Chapter 2).
In addition to the compulsive-like behavioral differences of the nest-building mice, the 
BIG and SMALL mice also differ in circadian rhythm organization. BIG and SMALL 
mice differ in their response to light pulses with the BIG mice having a larger phase- 
delay response (~2 hours) than SMALL mice (Bult et al., 1993). BIG mice also differ in 
activity profiles of wheel-running behavior, with BIG mice having fewer wheel 
revolutions (lower activity) and less robust circadian rhythms during a 1 2 :1 2  light-dark 
cycle and constant dark conditions, as compared to SMALL mice (Bult et al., 1993). In 
addition to controlling circadian behavior, the SCN also receive extensive serotonergic 
innervation from the raphe nuclei (Kawano et a l, 1996; Meyer-Bernstein et al., 1997). 
Importantly, the raphe nuclei also send serotonergic projections to cortical and striatal 
regions associated with OCD (Imai et al., 1986; Kosofksy and Molliver, 1987; Ohearn 
and Molliver, 1984; Vanbockstaele et al., 1993).
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Specific neuroanatomical abnormalities may underlie OCD. Imaging studies indicate 
that the limbic and orbitoffontal-basal ganglia-thalamocortical circuits are important in 
the pathogenesis of OCD (Saxena et a l, 1998; Graybiel and Rauch, 2000). Obsessions 
may be mediated by over-activity within the frontal cortex while arising from impaired 
thalamic gating fundamentally attributable to deficient striatal function (Micallef and 
Blin, 2001). In addition, the repetitive ritualized behaviors, or compulsions, might be 
the expressions of aberrant or compensatory striatal activity (Rauch and Jenike, 1993). 
The cortical and striatal regions receive extensive serotonergic innervation from the 
dorsal and/or median raphe nucleus (Imai et al., 1986; Kosofksy and Molliver, 1987; 
Ohearn and Molliver, 1984; Vanbockstaele et al., 1993). Therefore, the raphe nuclei are 
candidate brain regions for the 5-HT-specific drug-induced attenuation of compulsive­
like behaviors.
To test whether 5-HT pathways extending from the dorsal raphe nucleus are involved in 
compulsive-like nest-building behavior in BIG mice, 5,7-dihydroxytryptamine (5,7- 
DHT) lesions o f the dorsal raphe were performed indirectly via lesioning serotonergic 
fibers in the SCN of BIG male mice. These results were then replicated in an additional 
study by directly injecting 5,7-DHT into the dorsal raphe nucleus in BIG and SMALL 
male mice. If  the 5-HT pathways of the dorsal raphe nucleus control compulsive-like 
nesting behavior, then the 5-HT-specific lesions in the dorsal raphe nucleus should 
augment the levels of compulsive-like nesting behavior in BIG mice.
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Wheel-running activity was also tested as a control behavior. Wheel-running is a good 
control behavior because it is higher (1.5 times) in the SMALL mice than in BIG mice 
(Bult et al., 1993). Therefore, low levels of compulsive-like nesting behavior in the 
SMALL mice are not due to lower overall activity levels, and high levels of 
compulsive-like nesting behavior in the BIG mice are not due to higher activity levels. 
In addition, wheel-running activity as an indicator of activity level can be used as a 
control behavior for the effects of 5-HT-specific lesions on compulsive-like behaviors 
to confirm that changes observed in these behaviors are not due to lesion-induced 
changes in activity levels.
4.3. Methods
4.3.1. Animals
Mice were raised on wood shavings in polypropylene cages (27cm x 17cm x 12cm) 
under a 12:12 light-dark cycle at 22±1°C. Young animals were weaned at 19-21 days of 
age and housed with same-sex littermates until the start of the experiment. Food (Purina 
Mills, Lab Diet Mouse Diet #5015, St. Lous, Montana) and water was available ad 
libitum. All mice used in the experiment were approximately 50 days of age at the start 
of the experiment. Animal care and experimental procedures were approved by the 
University of Alaska Fairbanks Institutional Animal Care and U se Committee (IACUC  
#02-57; approved 12-16-02, IACUC #05-64; approved 1-12-06, current).
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4.3.2. Measuring Nest-Building Behavior
Procedures described in Bult and Lynch (1996, 1997, 2000) were used to test 
compulsive-like nesting behavior. Briefly, mice were provided with a roll of cotton 
(Mountain Mist cotton batting, Troy, Inc., Chicago, Illinois) in the cage-top food 
hopper. Twenty-four hours later the cotton was weighed and put back after the cage had 
been cleaned. Additional cotton was added when necessary. This procedure was 
repeated for an additional 3 days. Compulsive-like nesting behavior was quantified by 
the total nesting score, which was defined as the total amount of cotton used over a 4- 
day testing period. This test was performed for 4 weeks pre-surgery and for 3 to 4 
weeks after surgery.
4.3.3. Testing of Wheel-Running Behavior
Wheel-running was implemented as a control behavior to ensure that significant 
changes, if any, noted in nest-building levels of the mice were not due to changes in 
locomotor behavior. Locomotor activity was quantified following standard protocols 
(Amy et al., 2000; Yan et al., 2003; Castillo et al., 2004; Hochstetler, 2004). Briefly, 
wheel-running activity of individually housed mice was measured using 24.2-cm 
diameter Nalgene running wheels mounted in polycarbonate cages (21cm x 42cm x 
20cm) equipped with a magnetic switch and wood shaving bedding. Vitalview, a data 
collection system on a computer (Mini-Mitter Co., Inc., Bend, Oregon), was used to 
continuously record the number of wheel revolutions in 5-min bins. All cages were 
visually isolated and a white noise generator (LaFayette Instrument Co., Lafayette, IN)
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was used to minimize auditory disturbance. Activity data were analyzed with Actiview 
(MiniMitter) software. Data sets of 10-day intervals were analyzed because most 
analysis methods require at least 1 0  days of continuous data to obtain significant, 
reliable results (Levine et a l, 2002). This behavior was quantified for 3 weeks pre­
surgery and 3 weeks post-surgery.
4.3.4. Surgical Procedures. Anesthesia and Postoperative Care.
Surgical procedures were approved by the University of Alaska Fairbanks Institutional 
Animal Care and Use Committee (IACUC #02-57; approved 12/16/02, IACUC #05-64 
approved 1-12-06, current).
Standard sterile surgical procedures were used. Animals were anesthetized with a 76 
mg/kg ketamine hydrochloride (ketaset) and a 1 mg/kg medetomidine hydrochloride 
(dormitor) cocktail given intraperitoneally (IP). Anesthesia was reversed with 
atipamezole hydrochloride (Antiseden) 1 mg/kg subcutaneously (SC). The antibiotic 
Baytril was administered SC (10 mg/kg) 12 hours before and after surgery. Pain was 
managed with Ketoprofen SC (1 mg/kg) right after the surgery and daily for 2 days after 
surgery. To prevent dehydration, mice were given 0.25 ml of 0.9% sterile saline SC 
immediately after surgery and daily thereafter as needed.
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4.3.4.1. Indirect Lesions of the Dorsal Raphe via Lesioning the SCN
The 5-HT-specific neurotoxin 5,7-DHT was used to destroy 5-HT cell bodies in the 
dorsal raphe nucleus (Qian et a l, 1995; Nattie et a l, 2004). 5,7-DHT was aimed 
directly above the SCN and delivered bilaterally in two 300 nl injections o f 14.4 mg of 
free base. Injections were delivered over a 3-minute period using a Hamilton syringe. 
Steoreotaxic coordinates for the SCN were -0.10 mm posterior to bregma, -/+ 0.15 mm 
lateral to bregma, and 5.70 mm ventral to the top of the skull. The injection needle 
remained in position for 5 minutes post-injection to reduce 5,7-DHT leakage into the 
needle tract. Seven male mice (4 BIG and 3 SMALL mice) received bilateral 5-HT- 
neurotoxin lesions of the serotonergic input to the SCN. Ten control male mice (5 BIG 
and 5 SMALL mice) received bilateral sham lesions with vehicle (two 300 nl of 0.9% 
saline and .0 2 % ascorbic acid) injections.
4.3.4.2. Direct Lesions o f the Dorsal Raphe
The experimental animals received one 600 nl injection of 14.4 mg of free base. 
Injections were delivered over a 3-minute period using a Hamilton syringe. Steoreotaxic 
coordinates for the dorsal raphe nucleus were -4.72 mm posterior to bregma, 0.0 mm 
lateral to bregma, and 2.80 mm ventral to the top of the skull. The injection needle 
remained in position for 5 minutes post-injection to reduce 5,7-DHT leakage into the 
needle tract. Some BIG and SMALL mice were designated as sham mice, or surgery 
controls, and, therefore, instead of a neurotoxin injection, they received an injection of a 
vehicle (600 nl of 0.9% saline and .02% ascorbic acid).
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4.3.5. 5-HT Immunocytochemical Evaluation
Experimental animals were euthanized with an overdose of sodium pentobarbital (200 
mg/kg, IP) and transcardially perfused with a phosphate buffered 4% paraformaldehyde 
solution. Brains were removed and stored in 4% paraformaldehyde over night and 
stored in phosphate-buffered 30% sucrose (at least 24 hours) prior to sectioning. Brains 
were frozen in embedding matrix and were sectioned in 50pm sections using a Reichert 
Jung 1800 cryostat. Lesion site and completeness were assessed by staining the dorsal 
raphe nucleus (in both the direct and indirect lesion experiments) and the SCN (in the 
indirect lesion experiment) of lesioned and sham-control mice for 5-HT. Every other 
section was stained for 5-HT. The 5-HT cells were labeled using standard 
immunocytochemical techniques with an affinity purified rabbit anti-mouse 5-HT IgG 
(ImmunoStar, Inc; Hudson, WI, diluted to 1:20,000), anti-rabbit IgG made in goat 
(Vector, Burlingame, CA; 1:200), avidin-biotinylated horseradish peroxidase activated 
by 3,3’-diaminobenzidine tetrachloride (Sigma-Aldrich) (Amy et al., 2000; Castillo et 
al., 2004). Sections were then mounted on electrostatically charged slides and placed 
under coverslips with Permount (Biomedia, Foster City, CA). 5-HT cells in the dorsal 
raphe and SCN were visualized and optical density was assessed in the most medial 
section of the dorsal raphe and SCN for each mouse using an Axioplan 2 imaging 
microscope, a digital AxioCam camera, and AxioVision 3.0.6. Software (Carl Zeiss, 
Germany). Mice were categorized as complete lesion, partial lesion or control (which 
includes sham controls and unsuccessful lesions). The lesion determinations were done 
by a comparison of the average optical density o f the sham-lesioned mice to the surgery
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mice so that optical densities of complete lesions were less than 25% of the sham, 
partial lesions were 25-50% and no lesions were greater than 50% of the sham. Mice 
that had the median raphe lesioned in addition to the dorsal raphe (n=l, direct lesion 
experiment) were categorized as a complete lesions.
4.3.6. Statistical Evaluation
Repetitive nesting and wheel-running activities were analyzed separately by repeated- 
measures ANOVA (Analysis of Variance) with lesion (neurotoxin-lesion and sham- 
lesion), line (BIG, SMALL), and time (1-week or 10-day periods for the entire 
experiment) effects. The General Linear Models (GLM) procedure also included lesion 
x line, lesion x time, line x time interaction effects. Pair-wise differences were tested for 
significance using the Tukey Studentized Range Test when significant lesion or time 
effects were found. All statistics were done using SAS software (Version 9.1.3, Cary, 
NC).
4.4. Results
4.4.1. Immunocytochemistry Evaluation
4.4.1.1. Indirect Lesion Study
Seven weeks after the 5,7-DHT lesions, a large reduction of serotonergic fibers in the 
SCN was observed (Figs. 4.1 D, E, and F; tis=8 .6 8 , p<0.001). Quantification o f 5-HT 
staining in the raphe nuclei revealed a large reduction in the number of 5-HT 
immunoreactive cells in the dorsal raphe nucleus (Figs. 4.1 A, B, and C), but not in the
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median raphe nucleus (Fig. 4.1 C) (Region effect (medial dorsal raphe, anterior median 
raphe, medial median raphe): F2,4 5 = 1 8.74, p<0.0001; Lesion effect (lesion, sham/no 
lesion): Fi,45=4 8 .89, p<0.0001; Region x Lesion interaction effect: F2,45=41.40, 
p<0.0001). Because of the close proximity o f the SCN to the third ventricle, some o f the
5,7-DHT probably leaked into the cerebrospinal fluid and caused lesions of 5-HT cells 
in the dorsal raphe nucleus because of its proximity to the fourth ventricle. Due to the 
possible leakage, 5,7-DHT lesions were injected directly into the dorsal raphe nuclei to 
confirm the regional specificity.
4.4.1.2. Direct Lesion Experiment
The completeness of the lesions was assessed (see earlier section for detailed methods), 
and the 5,7-DHT lesions produced a large reduction of 5-HT neurons in the dorsal raphe 
nucleus of the BIG and SMALL mice. Quantification of 5-HT staining in the raphe 
nuclei revealed a large reduction in the number of 5-HT neuron cells in the median 
raphe nucleus in some of the lesioned mice. Mice that had the median raphe lesioned in 
addition to the dorsal raphe (n=l) were categorized as a complete lesions.
4.4.2. Effects o f Serotonergic Lesions on Nest-Building Behavior
4.4.2.1. Indirect Lesion Experiment
The BIG mice which received successful 5,7-DHT lesions (n=5) reduced repetitive 
nesting behavior to approximately 25% of pre-lesion levels, while sham-lesioned BIG 
mice did not change repetitive nesting levels (Fig. 4.2; Lesion effect (lesion, sham/no
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lesion): Fi,7-7.75, p<0.027; Time effect (weeks): F7s49=5.50, p<0.0001; Lesion x Time 
interaction effect: F7t49=6.06, p<0.0001). The SMALL mice did not respond to the 
lesion (data not shown), which may have been due to a floor effect (minimum value of 
nest-building has already been reached), as a result of their very low levels o f nest- 
building behavior.
4.4.2.2. Direct Lesion Experiment
Neurotoxin induced 5-HT-specific lesions in the raphe nuclei decreased levels of nest- 
building behavior in BIG mice (Fig 4.3; repeated measures ANOVA for lesion effect: 
Fi,4= 10.06, p<0.034; lesion by time interaction effect: F3>i2 = 6.78, p<0.007). The BIG 
mice showed a significant time effect also (repeated measures ANOVA for time effect: 
F3ji2 -  6.05, p<0.01), which appears to be an effect of the surgery, that was not specific 
to nest-building behavior. In comparison, the SMALL mice (Fig. 4.4; repeated 
measures ANOVA for lesion effect: Fi,n = 0.00, p>0.95; lesion by time (week) 
interaction effect: F(,m  =0.31, p>0.92) did not have a change in nesting behavior after 
receiving neurotoxin induced 5-HT-specific lesions. After surgery, the three groups 
(complete lesion, partial lesion, and sham/no lesion) in the SMALL mouse line 
expressed similar levels of repetitive nesting. A significant time effect was noted among 
the groups in the SMALL mouse line (repeated measures ANOVA Time (weeks) effect: 
F6.66 = 3.60, p<0.004), which appears to be an effect of the surgery, that was not specific 
to nest-building behavior. These results reveal that neurotoxin induced 5-HT-specific 
lesions in the neurons o f the raphe nuclei significantly decreased the compulsive-like
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nesting behavior of the BIG mice, while having no impact upon the nesting levels of 
SMALL mice.
4.4.2.3. Effects of Serotonergic Lesions on Wheel Running
Wheel-running behavior, measured as the average number of wheel revolutions per day 
in 5-min bins, did not significantly differ among the experimental and control groups in 
the BIG mouse line (Fig. 4.5; repeated measures ANOVA for lesion effect: Fi;5 =0.00, 
p>0.95; lesion by time (week) interaction effect: F735 = 5.23, p<0.0004). The BIG 
neurotoxin and the BIG sham/no lesion mice expressed similar patterns of wheel- 
running activity. Repeated measures ANOVA analysis revealed a time (week) effect 
(F?! ,3 5  4.13, p<0.002) for BIG mice. The groups within the S \1 A Id. mouse line had no
lesion effect (Fig. 4.6; Fi.n = 0.10, p>0.75), or lesion by time (week) interaction effect 
(F7 77 = 1.06, p>0.39). The SMALL mice did not show a time (week) effect (F7j77 = 
1.30, p>0.26) in wheel-running.
4.5. Discussion
Direct and indirect lesions of the dorsal raphe nucleus resulted in a decrease in 
compulsive-like nest-building behavior in BIG male mice without altering their overall 
locomotor behavior as compared to sham-lesion BIG mice. Nest-building was not 
significantly altered in the SMALL mice. However, this may have been due to a floor 
effect, since the nest-building levels of these mice was already very low. 
Immunocytochemical evaluation revealed a large reduction in the number of serotonin
8 6
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immunoreactive cells in the dorsal raphe nucleus in the lesioned mice, indicating that 
the decline in the compulsive-like nest-building was likely due to a loss o f serotonergic 
innervation. These data indicate that the effects of the serotonergic lesions were specific 
to nest-building behavior and not due to a general decrease in locomotor behavior.
These results are consistent with a role of 5-HT pathways in the control of compulsive­
like behaviors, as exemplified by the effectiveness of SSRIs in reducing compulsive­
like nesting levels (Chapters 2 and 3). However, the immediate effect of SSRIs is a 
reduction in 5-HT re-uptake and therefore an increase in 5-HT availability in the 
synaptic cleft (Li et al., 1997), while the lesions reduce 5-HT availability. These results 
appear to be contradictory. However, they are not necessarily contradictory since 
chronic SSRI treatment results in long-term changes in 5-HT receptor expression that 
cause a net decrease in 5-HT (Li et al., 1997).
In human OCD research, specific neuroanatomical abnormalities have been found. 
Imaging studies have indicated that the limbic and orbitofrontal-basal ganglia- 
thalamocortical circuits are important in the pathogenesis of OCD (Saxena et al., 1998; 
Graybiel and Rauch, 2000). Obsessions may be mediated by over-activity within the 
frontal cortex while arising from impaired thalamic gating fundamentally attributable to 
deficient striatal function (Micallef and Blin, 2001). Serotonergic lesions of the dorsal 
raphe nucleus may have interrupted the positive feedback loop, which may have been 
hyperactive in the BIG mice, resulting in a reduction o f compulsive-like nesting
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behavior. Repetitive ritualized behaviors, or compulsions, might be the expressions of 
aberrant or compensatory striatal activity (Rauch and Jenike, 1993). Resting state 
positron emission tomography (PET) and single photon emission computed tomography 
(SPECT) studies have revealed increased activity in the orbitofrontal cortex, anterior 
cingulate cortex, and striatum in OCD subjects as compared to healthy controls 
(Cannistraro and Rauch, 2003). Furthermore, symptom provocation studies of OCD 
subjects have demonstrated activations in the orbitofrontal cortex, anterior cingulate 
cortex, and striatum, e.g., increased metabolism and blood flow, in the symptomatic 
state as compared to the neutral state. Behavioral and pharmacotherapy treatment 
reduces hyperactivity in these areas (Cannistraro and Rauch, 2003). The cortical and 
striatal regions receive extensive serotonergic innervation from the dorsal and/or 
median raphe nucleus (Imai et al., 1986; Kosofksy and Molliver, 1987; Oheam and 
Molliver, 1984; Vanbockstaele et a l, 1993). These data indicate that the compulsive­
like mouse model and human OCD patients may have similar underlying neural 
mechanisms for the expression of compulsive behaviors.
More targeted lesions within the dorsal raphe nucleus and possibly the median raphe 
nuclei are necessary to further elucidate a more specified role of 5-HT pathways in 
mouse compulsive-like nesting. In addition, studies are currently underway to determine 
if there are any neurobiological differences present between the BIG and SMALL mice 
in brain areas and receptors that have previously been implicated in the neurobiology of 
human OCD, such as the 5H T ja, 5-H T id, 5-HT2A, and 5-HT2C receptors (Delgado and
8 8
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Moreno, 1998; Koran et al., 2001; Mansari and Blier, 2005).
This proposed model is novel in that it is a spontaneous, non-induced behavioral model 
and has the potential to greatly contribute to the study of OCD by providing additional 
indications of neural pathway involvement and a novel approach to investigate the 
mechanisms underlying OCD in humans. Once this model is confirmed as a mouse 
model of OCD, the use of the compulsive-like nesting mice as a screening tool for 
potential drug therapies may be possible. Potentially this mouse model may be used to 
elucidate neural pathway involvement in OCD and lead to a cure for OCD.
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Figure 4.1. Representative digital images of serotonin immunocytochemical 
staining in the dorsal raphe nucleus. Representative images of are from medial 
sections of the dorsal raphe nucleus (DR) (A, B) and the suprachiasmatic nucleus (SCN) 
(D, E). . Representative images o f serotonin staining of sham-lesion mice (A, D) and
5,7-DHT-lesion mice (B, E) are shown. Arrows indicate similar regions in the dorsal 
raphe nucleus. Scale bar, 100pm. Cell counts of serotonin immunoreactive (ir) cells in 
medial sections of the dorsal raphe nucleus, and anterior and medial sections of the 
median raphe nucleus of each animal are shown (C). Relative optical densities of 
serotonin staining of medial sections of the SCN are shown (F). *p<0.05 or 
**p<0.0001, Tukey.
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Figure 4.2. The effects of indirect serotonergic dorsal raphe nucleus lesions on 
nest-huilding in BIG mice. Nest-building of BIG mice which received successful 5,7- 
DHT lesions (open symbols) and sham and no lesion BIG (filled symbols) is expressed 
as percent of the average of pre-surgery weeks 2-4. The dashed line indicates the 4- 
week recovery period after surgery before subsequent behavioral testing was performed. 
All significant points are indicated *p<0.05, Tukey.
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Figure 4.3. The effects of direct serotonergic lesions of the dorsal raphe on nest- 
building of BIG mice. Nest-building of BIG mice which received successful 5,7-DHT 
lesions (open symbols) and sham and no lesion BIG (filled symbols) is expressed as a 
percent of the average of pre-surgery weeks 2-3. The dashed line indicates the 4-week 
recovery period after surgery before subsequent behavioral testing was performed. All 
significant points are indicated *p<0.05, Tukey.
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Figure 4.4. The effects of direct serotonergic lesions of the dorsal raphe nucleus on 
nest-building behavior in SMALL mice. Open square symbols represent complete 
lesion mice, open diamond symbols represent partial lesion mice and filled diamond 
symbols represent mice that were shams or did not receive a successful lesion. The 
dashed line indicates the 4-week recovery period mice were given before subsequent 
behavioral testing after their surgeries.
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Figure 4.5. The effects of serotonin-specific neurotoxin-induced lesions on wheel 
running in BIG mice. Wheel running activity (average daily number o f revolutions per 
5 minute bin) of BIG mice is shown. Open square symbols represent lesion mice, filled 
diamond symbols represent mice that were shams or did not receive a successful lesion. 
The dashed line indicates the 4-week recovery period mice were given before 
subsequent behavioral testing after their surgeries.
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Figure 4.6. The effects of serotonin-specific neurotoxin-induced lesions had on 
wheel-running in SMALL mice. Wheel running activity (average daily number of 
revolutions per 5 minute bin) of SMALL mice is shown. The dashed line indicates the 
4-week recovery period before subsequent behavioral testing after their surgeries. Open 
square symbols represent lesion mice, open diamond symbols represent partial lesion 
mice and filled diamond symbols represent mice that were shams or did not receive a 
successful lesion.
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CHAPTER 5 
General Conclusions
The essential lack o f animal models with robust and spontaneous (non-drug or non- 
behaviorally induced) compulsive-like behaviors has inhibited progress in the 
identification of specific neural dysfunctions involved in the expression of compulsive­
like behaviors. The goal of this research was to validate a novel robust and spontaneous 
genetic mouse model of OCD, and begin to identify OCD-relevant biochemical 
mechanisms and functional correlates in brain regions implicated in OCD neural 
dysfunction. An effective animal model o f OCD needs to focus on specific behavioral, 
neurochemical, pharmacological and structural brain anomalies that are homologous to 
OCD in humans. Previous researchers have specified certain requirements for an animal 
model system, which include face, predictive and construct validity (Korff and Harvey, 
2006; McKinney and Bunney, 1969; Wilner, 1991).
In order for an animal model of OCD to have good face validity it should include 
symptoms that are reasonably analogous to human symptoms and behavioral changes 
that are measurable in an objective manner (Korff and Harvey, 2006; McKinney and 
Bunney, 1969; Wilner, 1991). The compulsive-like nest-building behavior in BIG mice 
has good face validity, with a behavioral phenotype that is similiar to that o f  
compulsive-like behaviors seen in humans with OCD. The compulsive-like nest- 
building of BIG mice is a stable and spontaneous behavior which is easily measured 
(Bult and Lynch, 1996, 1997, 2000; Lynch, 1980). In addition, male and female BIG
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mice displayed a three-fold elevation in compulsive-like digging behavior relative to 
SMALL mice, as assessed in a standard marble-burying assay (Chapters 2 and 3). These 
finding provide face validity, supporting the potential utility of BIG mice as an animal 
model of OCD.
Predictive validity is also necessary, such that the treatment effective in OCD (e.g., 
SSRIs) should have the same effect on the animal condition (Korff and Harvey, 2006; 
McKinney and Bunney, 1969; Wilner, 1991). Both chronic oral fluoxetine and 
clomipramine treatment reduced compulsive-like nest-building behavior in male BIG 
mice, while desipramine did not significantly alter this behavior (Chapter 2). 
Furthermore, chronic oral fluoxetine administration decreased nest-building behavior of 
BIG mice in a dose-dependent manner (Chapter 2). Fluoxetine is a commonly 
prescribed serotonin re-uptake inhibitor for the treatment of OCD symptoms in humans 
(Goodman et a l, 1990; Greist, 1998; Micallef and Blin, 2001). The latency to peak 
effect found in these studies was also similar to the delayed response of SSRIs in human 
OCD patients (Man, et al., 2004). Importantly, the administration of fluoxetine did not 
cause a decrease in general locomotor behavior, as assessed by wheel-running activity 
(Chapter 2). In addition, chronic oral fluoxetine treatment augmented compulsive-like 
digging behavior in male and female BIG mice as compared to SMALL mice, as 
assessed by the marble-burying test (Chapter 2). Combined, these findings suggest that 
the nest-building phenotype has excellent predictive validity for modeling OCD in 
humans.
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Interestingly, clomipramine did not reduce nest-building in female BIG mice. These 
data are in contrast to BIG male mice treated with clomipramine (80 mg/kg/day), where 
male BIG mice had a significant decrease in nest-building behavior (Chapter 2). Gender 
differences in treatment response in human OCD have been previously established 
(Mundo et al., 1999) as well as in other serotonin-related disorders (Camarena et al., 
2001; Komstein et al., 2000; Lewis-Hall et al., 1997; Schneider et al. 1997; Steiner et 
al., 1990; Wilson et al., 1989; Wolk & Weissman, 1995). Differential expression in 
treatment responses between male and female OCD patients’ may be a result of 
underlying genetic differences as well as gonadal hormone differences (Borisova et al., 
1996; Cloitre et al., 2004; Cowbum and Payne, 1994; Zhang et al., 1997).
An animal model should also have construct validity in which the model either relies on 
or elucidates the same underlying mechanism responsible for OCD in humans (Korff 
and Harvey, 2006; Overall, 2000). The nest-building behavior exhibited by these mice 
has a genetic component in which approximately 30% of the variation among 
individuals within a selected line in the expression of the behavior can be attributed to 
additive genetic factors, while approximately 70% of the variation is mostly due to 
environmental factors (Bult and Lynch, 2000; Lynch, 1980). This is important because 
OCD also appears to have genetic as well as environmental components (Hettema et al., 
2001). Nesting behavior is also a highly polygenic trait (Bult and Lynch, 2000), which 
is consistent with OCD probably being influenced by many different genes. Additional 
construct validity is implicated by the results of targeted serotonergic lesions o f the
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raphe nuclei in male BIG mice, in which successful 5,7-DHT lesions reduced 
compulsive-like nesting behavior in BIG mice to approximately 25% of pre-lesion 
levels, while not affecting locomotor activity as compared to sham BIG mice (Chapter
4).
More targeted lesions within the dorsal raphe nucleus and possibly the median raphe 
nuclei are necessary to further elucidate a more specified role of 5-HT pathways in 
mouse compulsive-like nesting. In addition, studies are currently underway to 
confirmation the role o f 5-HT and its receptors in compulsive-like nest-building. 
Serotonergic receptor roles could be elucidated by the use o f a serotonin agonist, such 
as metachlorophenylpiperazine (mCPP; a preferential 5-HT2C receptor agonist), that 
has been shown to increase compulsive behaviors in OCD patients (Erzegovesi et al.,
2001). In addition to serotonin, dopamine has been implicated in OCD, so it will be 
necessary to assess the effects of dopamine on compulsive-like nesting, such as by the 
administration of quinpirole, a dopamine D2/D3 receptor agonist that has been shown to 
increase compulsive-like behaviors in rats (Dvorkin et al., 2006) and by SCH 23390, a 
D1 receptor antagonist, that has been show to decrease them in rats (Joel and Doljansky, 
2003). The elucidation of baseline extracellular and whole tissue content of 5-HT and 
dopamine in the frontal cortex, thalamus, and striatum, areas associated with OCD 
(Saxena et a l, 1998; Graybiel and Rauch., 2000) through biochemical analyses using 
microdialysis and high performance liquid chromatography would also be beneficial in 
understanding the neurochemistry involved in the compulsive-like nest-building of the
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BIG mice.
In conclusion, this proposed model is novel in that it is a spontaneous, non-induced 
behavioral model with good face, predictive and construct validity that has the potential 
to be of great benefit to the study of OCD. Using the BIG mouse line as a screening tool 
for drug and therapeutic development may now be possible. Through the use of this 
mouse model, gaining insights in neural mechanisms controlling compulsive-like 
behaviors, the development of effective treatments and a potential cure for OCD may 
also be possible.
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